Updated n 18th of February 2021

CURRICULUM VITAE

PETER BJERRING, M.D., Dr.Sci. (Med.)

FAAD, FASLMS, FEADV, FESLD R

Born: 19 March 1953 in Aarhus, Denmark. Languages: Danish, English, Swedish, French, German Expert areas: Classical dermatology Laser dermatology Cosmetical laser dermatology Medical cosmetic dermatology Dermatological surgery Skin cancer treatment Photodermatology Medical and Scientific Education and Authorizations: 1980: Medical Doctor, University of Aarhus, Denmark 1986: Received the University of Aarhus’ Research Prize – awarded the Gold Medal 1988: Board Certified as a specialist in dermatology and venerology by The Danish National

Board of Health 1991: Dr. Sci. (Med.), Doctoral Thesis, University of Aarhus, Denmark 2001: Board Certified as a specialist in dermato-venereology in Norway 2004: Board Certified as a specialist in dermato-venereology in The Netherlands Appointments: 1980-1982: Residencies in internal medicine, general surgery, and dermatology at Aarhus

University Hospital, Aarhus, Denmark 1982-1983: Research fellow, The Danish Cancer Foundation, Aarhus, Denmark 1983-1990: Residencies in dermatology, internal medicine, and tropical medicine at the University

Hospital, Aarhus and at the University Hospital, Odense, Denmark 1990-1995: Associate professor of dermatology at the University of Aarhus, Denmark and

consultant (Faculty Member) at the Department of Dermatology, University Hospital, Aarhus, Denmark. Clinical Lecturer, Aarhus University.

1993-: Consultant, Department of Dermatology, Molholm Hospital, Vejle, Denmark 1995-2004: Professor at the Department of Dermatology, University Hospital of Aarhus, Denmark

(Laser-Dermatology) 2004-2018: Chief Physician (Medical Director) at the Molholm Hospital, Vejle 2001-2007: CEO, Molholm Hospital, Vejle, Denmark 2005-2019: Honorary Professor, Faculty of Life Sciences, Swansea University, Swansea, Wales,

UK 2018-: Consultant, Department of Dermatology, Molholm Hospital, Vejle, Denmark 2018-: Senior Faculty Member. Department of Dermatology, Bispebjerg Hospital,

Copenhagen 2018-: Chief Physician (Medical Director), Dermatology Lab, Copenhagen 2019-: Professor (Full), Consultant, and Senior Faculty Member, Department of Dermatology, Aalborg

University Hospital, Aalborg, Denmark Address: Department of Dermatology, Aalborg University Hospital, Hobrovej 18-22, 9000, Aalborg, Denmark

Department od Dermatology, Molholm Private Hospital, Brummersvej 1, DK-7100 Vejle, Denmark

Private Address: Stationsgade 4, DK-8240 Risskov, Denmark, and Islands Brygge 36C, 2300, Copenhagen.

Emails: email@peterbjerring.dk, and p.bjerring@rn.dk. Mobile phone +45 4063 4878

CV Peter Bjerring, Professor, MD, Dr.Sci

Scientific Activities – Overview:

1. University Gold Medal Award

2. Doctoral Thesis

3. Publications in peer reviewed scientific journals

4. Patents

5. Book chapters

6. Oral contributions to scientific congresses

7. Congress presentations – posters

8. Editorial boards

9. Journal referee

10. Fellowships: Scientific societies and -associations

11. Boards and Committees

12. Scientific supervision

13. External examinator at Ph.D Theses and Doctoral Dissertations

14. Honours

1: Aarhus University Research Prize, - awarded the Gold Medal:

Aarhus University

In vivo Human Skin Reflectance Spectroscopy, 1986.

2: Doctoral Thesis

Aarhus University:

Quantitative monitoring and attenuation of acute experimental cutaneous pain and inflammatory vascular

reactions. - Effect of local analgesics, capsaicin and antihistamines.

Thesis defended in public: June 28th, 1991.

3: Publications

1. Bjerring P, Thestrup-Pedersen K. E-rosette formation of lymphocytes from patients with atopic

dermatitis. Acta Derm Venereol 1982; 62: 31-34.

2. Bjerring P, Thestrup-Pedersen K, Zachariae H. Treatment of Kaposi's varicelliform eruption with

adenine arabinoside (Vira-A) and transfer factor. Acta Derm Venereol 1982; 62: 85-87.

3. Zachariae H, Bjerring P. Methotrexate in psoriasis with and without leucovorin: Effect of different

dosage schedules on acute liver toxicity. Acta Derm Venereol 1982; 62: 446-448.

CV Peter Bjerring, Professor, MD, Dr.Sci

4. Thorling E B, Overvad K, Bjerring P. Oral selenium inhibits skin reactions to UV light in hairless

mice. Acta Path Microbiol Scand 1983; 91: 1-5.

5. Zachariae H, Bjerring P, Grunnet E, Thestrup-Pedersen K, Davidsen D: Results of lymphography

in early mycosis fungoides. Acta Derm Venereol 1983; 63: 1-11.

6. Møller B R, Bjerring P, Rasmussen I, From E. Konjunctivitis hos voksne forårsaget af genitale

klamydier. Ugesk Læg 1983; 145: 3100.

7. Foged E, Bjerring P, Kragballe K, Søgaard H, Zachariae H. Histologic changes in the liver during

etretinate treatment. J Am Acad Dermatol 1984; 11: 580-583.

8. Zachariae H, Foged E, Bjerring P, Kragballe K, Søgaard H. Liver biopsy during etretinate (tigason)

treatment. In: Saurat (ed) Retinoids: New trends in research and therapy. Retinoid Symposium,

Geneva 1984, pp 494-497 (Karger, Basel 1985).

9. Bech H-I, Bjerring P, Brandt Nielsen E: Hypertrichose. Månedsskr Prakt Lægeg 1984; 5: 313-317.

10. Ebbesen, P, Villadsen J H, Langkjer S T, Bjerring P. Suspectibility of carcinogenic effect of

irridation. Relationship to age at time of exposure. Acta Radiologica Oncology 1984; 23 (Fasc 2-

3):141-145.

11. Bisballe S, Thestrup-Pedersen K, Bjerring P, Jensen J R, Ottosen P D, Kaltoft K: Eosinophilic

granuloma associated with a 16q22 chromosomal defect of cutaneous lymphocytes. Acta Derm

Venereol (Stockh) 1984; 64: 548-551.

12. Beck HI, Bjerring P, Rasmussen I, Zachariae H, Stenbjerg S: Treatment of necrobiosis lipoidica

with low dose acetylsalicylic acid. Acta Derm Venereol (Stockh) 1985; 65: 230-234.

13. Bjerring P. Skin elasticity measured by dynamic admittance - a new technique for mechanical

measurements in patients with scleroderma. Acta Derm Venereol (Stockh) 1985; suppl 120: 84-87.

14. Overvad K, Thorling E B, Bjerring P, Ebbesen P. Selenium inhibits UV-light-induced skin

carcinogenesis in hairless mice. Cancer Letters 1985; 27: 163-170.

15. Bjerring P. Intratumoural light distribution in an experimental mouse tumour irradiated by a diffuse-

light irradiator compared with unilateral helium-neon laser light for photodynamic therapy. Int J

Radiat Biol 1987; 52: 191-199.

16. Øberg B, Bjerring P. Pneumatic surgical instruments and postoperative infection. Lancet 1985:

1436.

17. Bjerring P, Øberg B: Bakterial contamination of compressed air for medical use. Anaesthesia 1986;

41: 148-150.

18. Bjerring P, Beck H I, Zachariae H, Søgaard H. Topical treatment of psoriatic skin with methotrexate

cream. Acta Derm Venereol (Stockh) 1986; 66: 515-519.

19. Hansen J B, Bjerring P, Buchardt O, Ebbesen P, Kanstrup A, Karup G, Knudsen P H, Nielsen P E,

Norden B, Ygge B. Psoralenamines. 3. Synthesis, Pharmacological behaviour, and DNA binding of

5-(Aminomethyl)-8-methoxy, 5(((3-Aminopropyl) oxy)methyl)- and 8-((3-Aminopropyl) oxy)

psoralen derivatives. J Med Chem 1985; 28: 100l-1010.

20. Halkier-Sørensen L, Bjerring P, Cramers M. Phototoxicity testing of Fenflumizole, a human model.

Photodermatology 1986; 3, 242-244.

21. Zachariae H, Bjerring P, Foged E K. Laserbehandling af kapillære hæmangiomer og multiple

teleangiektasier. Ugeskr Læg 1986; 148: 77-79.

22. Øberg B, Bjerring P. Comparison of microbiological contents of compressed air in two Danish

hospitals. Effect of oil and water reduction in Air-generating units. Acta Anaesth Scand 1986; 30,

305-308.

CV Peter Bjerring, Professor, MD, Dr.Sci

23. Halkier-Sørensen L, Ternowitz T, Bjerring P, Poulsen J H, Alsbirk K E, Herlin T, Ravnsbæk J,

Zachariae E, Zachariae H. Benoxaprofen in treatment of systemic sclerosis. Acta Derm Venereol

(Stockh) 1986; 66: 177-179.

24. Bjerring P, Øberg B: Possible role of vacuum systems and compressed air generators in cross

infections in the ICU. Br J Anaesth 1987; 59, 648-650.

25. Bjerring P, Øberg B. Bacterial contamination of compressed air for medical use. Infect Diseases

Digest 1986; 7: 28-29.

26. Langkjer S T, Villadsen J H, Bjerring P, Ebbesen P. A suction blister method that gives epidermal

biopsies from mice of different ages, suitable for histologic studies of Langerhans cells. Compr

Gerontol A 1987; 1: 75-77.

27. Beck H I, Bjerring P. House-dust mites and human dander. Allergy 1987; 42: 471-472.

28. Wätjen F, Buchardt O, Langvad E, Bjerring P, Langkjer S T, With M: Synthesis, tissue distribution

and cytostatic properties of two new daunorubic derivatives of 2-thiouracil containin a guanidine

bridge. Drug Design and Delivery 1986; 1: 131-142.

29. Ternowitz T, Bjerring P, Andersen P, Schrøder J M, Kragballe K. Methotrexate inhibits the human

C5a induced skin response in patients with psoriasis. J Invest Dermatol 1987; 89: 192-196.

30. Bjerring P, Andersen P: Skin reflectance spectrophotometry. Photodermatology 1987; 4: 167-171.

31. Arendt-Nielsen L, Bjerring P. Objektiv Målemetode til kvantitering af smerte. Ugeskr Læg 1987;

149, 2710-2713.

32. Villadsen J H, Langkjer S T, Ebbesen P, Bjerring P. Syngrafting skin among mice of similar and

different ages increases the number of Langerhans cells and decreases responsiveness to 1,4-

dinitrofluorobenzene. Compr Gerontol A 1987; 1:78-79.

33. Arendt-Nielsen L, Bjerring P. Sensory and pain Thresholds characteristics to laser stimuli. J Neurol

Neurosurg Psychiatry 1988; 51: 35-42.

34. Arendt-Nielsen L, Bjerring P: Reaction times to painless and painful CO2 and argon laser

stimulation. Eur J Appl Physiol 1988; 58: 266-273.

35. Arendt-Nielsen L, Bjerring P, Rosenfalck A. Kvantificering af laser-inducerede smerter. Medicin og

Teknik 1988; 1: 3-5.

36. Arendt-Nielsen L, Bjerring P. Selective averaging of argon laser induced pre-pain and pain related

cortical responses. J Neurosci Methods 1988; 24: 117-123.

37. Bjerring P, Arendt-Nielsen L. EMLA creme til overflade analgesi. Teori og Terapi 1988; 3: 22-24.

38. Beck H I, Bjerring P, Harving H. Atopic dermatitis and the indoor climate. - Preventive measures

related to the indoor climate. Acta Derm Venereol (Stockholm) 1989; 69: 162-165.

39. Studstrup L, Beck H I, Bjerring P, Wulf H C, Lund-gren K. No detectable increase sister chromatid

exchanges in lymphocytes from mycosis fungoides patients after topical treatment with nitrogen

mustard. Br J Dermatol 1988; 119: 711-715.

40. Rattan S I S, Rasmussen L M, Bjerring P, Bhatia P, Clark B F C: Unchanged concentrations of

plasma fibronectin in Alzheimer's disease. J Clin Path 1988; 41: 476.

41. Beck H-I, & Bjerring P. Skin blood flow in necrobiosis lipoidica during treatment with low-dose

acetylsalicylic acid. Acta Derm Venereol (Stockh) 1988; 68: 364-365.

42. Illum P, Bjerring P. Hereditary hemorrhagic teleangiectasia treated by laser surgery. Rhinology

1988; 26: 19-24.

CV Peter Bjerring, Professor, MD, Dr.Sci

43. Zachariae H, Bjerring P, Cramers M: Argon laser treatment of cutaneous vascular lesions in

connective tissue diseases. Acta Derm Venereol (Stockh) 1988; 68: 179-182.

44. Bjerring P, Arendt-Nielsen P. Laser pain threshold testing. Anaesth Topics 1987; 6: 5-6.

45. Bjerring P, Arendt-Nielsen L. Argon laser induced single cortical responses: a new method to

quantify pre-pain and pain perceptions. J Neur Neurosurg Psychiatry 1988; 51: 43-49.

46. Arendt-Nielsen L, Bjerring P: Laser induced pain for evaluation of local analgesia - A comparison of

topical application (EMLA) and local injection (Lidocaine). Anaesth Analg 1988; 67: 115-123.

47. Arendt-Nielsen L, Bjerring P. Evaluation of acetaminophen (Setamol) analgesia by argon.

Proceedings ISEK, 1988; 195-198.

48. Rattan S I S, Rasmussen L M, Bjerring P, Bhatia P, Clark B F C. Human plasma fibronectin levels

during ageing, Alzheimer's disease and cancer. Trends in Biomedical Gerontology 1988;1: 61-62.

49. Arendt-Nielsen L, Bjerring P. The Effect of topically applied anaesthetics (EMLA cream) on

threshold to thermode and argon laser stimulation. Acta Anaesthesiol Scand 1989; 33: 469-473.

50. Christoforidis E C, Hovendal C, Bjerring P, Kruse A. Continuous measurement of gastric blood flow

by laser-Doppler flowmetry during gastroscopy. Scand J Gastroenterol 1989; 24: 16-20.

51. Bjerring P, Arendt-Nielsen L. A quantitative comparison of the effect of local analgesics on argon

laser induced cutaneous pain and on histamine induced wheal, flare and itch. Acta Derm Venereol

(Stockh) 1990; 70: 126-131.

52. Bjerring P, Arendt-Nielsen L, Andersen P. Vascular response of human skin after analgesia with

EMLA cream. Br J Anaesth 1989; 63: 655-660.

53. Bjerring P, Arendt-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical

application of EMLA cream. Br J Anaesthesia 1990; 64: 173-177.

54. Bjerring P, Arendt-Nielsen L. Use of a new argon laser technique to evaluate changes in sensory

and pain thresholds in human skin following topical capsaicin treatment. Skin Pharmacology 1989;

2:162-167.

55. Zachariae R, Bjerring P, Arendt-Nielsen L. Modulation of type I immediate and type IV delayed

immunoreactivity using direct suggestion and guided imagery during hypnosis. Allergy 1989; 44:

907-912.

56. Bjerring P, Arendt-Nielsen L, Søderberg U. Argon laser induced cutaneous sensory and pain

thresholds in post-herpetic neuralgia. Quantitative modulation by topical capsaicin. Acta Derm

Venereol (Stockh) 1990; 70: 121-125.

57. Arendt-Nielsen L, Anker-Møller E, Bjerring P, Spangsberg N. Onset phase of of spinal bupivacaine

analgesia assessed quantitatively by laser stimulation. Br J Anaesthesia 1990; 65: 639-642.

58. Arendt-Nielsen L, Øberg B, Bjerring P. Analgesic effect of intra-muscular alfentanil. Br J Anaesth

1990; 65: 164-168.

59. Bjerring P, Arendt-Nielsen L. Inhibition of histamine skin flare reaction following repeated topical

applications of capsaicin. Allergy 1990; 45: 121-125.

60. Arendt-Nielsen L, Zachariae R, Bjerring P. Quantitative evaluation of hypnotically suggested

hyperaesthesia and analgesia by painful laser stimulation. Pain 1990; 42: 243-251.

61. Andersen P H, Bjerring P. Spectral reflectance of human skin in vivo. Photodermatology 1990;7:5-

12.

CV Peter Bjerring, Professor, MD, Dr.Sci

62. Ternowitz T, Andersen PH, Bjerring P, Fogh K. Schrøder JM, Kragballe K. 15-hydroxyeicosa-

tetraenoic acid (15-HETE) specifically inhibits the LTB-induced skin response. Arch Dermatol Res

1989; 281: 401-405.

63. Bjerring P. Effect of antihistamines on argon laser-induced cutaneous sensory and pain thresholds

and on histamine-induced wheal and flare. Skin Pharmacol 1989; 2: 210-216.

64. Arendt-Nielsen L, Kaalund S, Bjerring P, Høgsaa B. Insufficient effect of local analgesics in Ehlers

Danlos type III patients (Connective tissue disorder). Acta Anaesth Scand 1990; 34: 358-361.

65. Nielsen J, Bjerring P, Arendt-Nielsen L. A comparison of the hypoalgesic effect of paracetamol in

slow-release and plain tablets on laser induced pain. Br J Clin Pharmac 1991; 31: 267-270.

66. Zachariae B, Bjerring P. Hyperhidrose. Hypnoterapeutisk behandling af to patienter med

hyperhidrose. Ugeskr Laeger 1990; 152: 2863-2864.

67. Arendt-Nielsen L, Øberg B, Bjerring P. Laser-induced pain for quantitative comparison of

intravenous regional anesthesia using saline, morphine, lidocaine or prilocaine. Regional

Anesthesia 1990; 15: 186-193.

68. Arendt-Nielsen L, Bjerring P, Nielsen J. Regional variations in analgesic efficacy of EMLA cream.

Quantitatively evaluated by argon laser stimulation. Acta Derm Venereol (Stockh) 1990; 70: 314-

318.

69. Bjerring P, Arendt-Nielsen L. Kløens neurofysiologi. Urticaria Symposium, Eds: Flemming

Brandrup, Poul Ølholm Larsen. Glaxo, Danmark 1989, pp 11-19.

70. Kaalund S, Arendt-Nielsen L, Bjerring P, Høgsaa B, Crevy C. The response to local anaesthetics

(EMLA) as a clinical test to diagnose between hypermobility and Ehlers Danlos Type III patients.

Scand J Rheumatol 1991; in press.

71. Nielsen J, Bjerring P, Arendt-Nielsen L, Petterson KJ. A double-blind, placebo controlled, cross-

over comparison of the analgesic effects of ibuprofen 400 mg and 800 mg on laser-induced pain.

Br J Clin Pharmacol 1990; 30: 711-715.

72. Harving H, Korsgaard J, Dahl R, Beck H-I, Bjerring P. House dust mites and atopic dermatitis. A

case-control study on the significance of house dust mites as etiologic allergens in atopic

dermatitis. Annals of Allergy 1990, 65; 1: 25-31.

73. Arendt-Nielsen L, Bjerring P, Dahl J B. A quantitative double-blind evaluation of the antinociceptive

effects of perineurally administered morphine compared with lidocaine. Acta Anaesthesiol Scand

1991; 35: 24-29.

74. Sindrup S H, Brøsen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo H R, Gram L F. Codeine

increases pain thresholds to copper vapour laser stimuli in extensive but not poor metabolizers of

sparteine. Clinical Pharmacology and Therapeutics 1991; 49: 686-693.

75. Brennum J, Arendt-Nielsen L, Secher NH, Jensen TS, Bjerring P. Quantitative sensory

examination in human epidural anaesthesia and analgesia: effects of lidocaine. Pain 1992; 51(1):

27-34

76. Svensson P, Bjerring P, Arendt-Nielsen L, Kaaber S. Quantitative determinations of sensory and

pain thresholds on human oral mucosa by argon laser stimulation. Pain 1992; 49: 233-239.

77. Zachariae R, Bjerring P, Arendt-Nielsen L, Nielsen T, Gotliebsen K. The effect of hypnotically

induced emotional states on brain potentials evoked by painful argon laser stimulation. Clin J Pain

1991; 7(2): 130-138.

78. Zachariae R, Bjerring P. The effect of hypnotically induced analgesia on flare reaction of the

cutaneous histamine prick test. Archives of Dermatological Research 1990; 282: 539-543.

CV Peter Bjerring, Professor, MD, Dr.Sci

79. Andersen P H, Nangia A, Bjerring P, Maibach H I. Chemical and pharmacologic skin irritation in

man. Contact Dermatitis 1991; 25(5): 283-289.

80. Andersen P H, Bjerring P. A comparative evaluation of sun protective properties of a shea butter

by reflectance spectroscopy, laser Doppler flowmetry and visual scoring. Skin Pharmacology and

Toxicology, 1990; 181: 267-276.

81. Andersen P H, Bjerring P. Non-invasive computerized analysis of skin chromophores in vivo by

reflectance spectroscopy. Photodermatol Photoimmunol and Photomed 1990; 7 (6): 249-257.

82. Svensson P, Bjerring P, Arendt-Nielsen L, Nielsen J, Kaaber. Comparison of four laser types for

experimental pain stimulation on oral mucosa and hairy skin. Lasers Surg Med 1991; 11: 313-324.

83. Arendt-Nielsen L, Øberg B, Bjerring P. Quantitative assessment of extradural bupivacaine

analgesia. Br J Anaesth 1990; 65: 633-638.

84. Arendt-Nielsen L, Øberg B, Bjerring P. Hypoalgesia following epidural morphine: A controlled

quantitative experimental study. Acta Anaesthesiol Scand 1991; 35: 430-435.

85. Arendt-Nielsen L, Anker-Møller E, Bjerring P, Spangsberg N. Hypoalgesia following intrathecal

morphine. A segmental dependent effect. Acta Anaesthesiol Scand 1991; 35: 402-406.

86. Nielsen J C, Bjerring P, Arendt-Nielsen L, Carlsson P. Analgesic efficacy of low doses of

intravenously administered lidocaine on experimental laser induced pain: A placebo controlled

study. Regional Anesthesia 1991; 16: 28-33.

87. Svensson P, Bjerring P, Arendt-Nielsen L, Kaaber S. Variability of argon laser-induced sensory

and pain thresholds on human oral mucosa. Anesth Progr 1991; 38: 79-83.

88. Svensson P, Arendt-Nielsen L, Bjerring P, Kaaber S. Oral mucosal analgesia quantitatively

assessed by argon laser-induced thresholds and single-evoked vertex potentials. Anesthesia &

Pain Control in Dentistry 1993; 2: 154-161.

89. Arendt-Nielsen L, Gregersen H, Toft E, Bjerring P. Involvement of pain afferents in carpal tunnel

syndrome: Evaluated quantitatively by argon laser stimulation. Muscle & Nerve 1991; 14: 508-514.

90. Anker-Møller E, Spangsberg N, Arendt-Nielsen L, Schultz P, Carlsson P, Bjerring P. Subhypnotic

doses of thiopentone and propofol cause analgesia to experimentally induced pain. Br J

Anaesthesiol 1991; 66: 185-188.

91. Arendt-Nielsen L, Nielsen J, Bjerring P. Double-blind, placebo controlled comparison of

paracetamol and paracetamol plus codeine - A quantitative evaluation by laser induced pain. Eur J

Clin Pharmacol 1991; 40: 241-247.

92. Schonemann N K, van-der-Burght M, Arendt-Nielsen L, Bjerring P. Onset and duration of

hypoalgesia of lidocaine spray applied to oral mucosa - a dose response study. Acta Anaesthesiol

Scand 1992; 36: 733-735.

93. Petersen C S, Bjerring P, Larsen J, Blaakær J, Hagdrup H, From E, Obergaard L. Systemic

interferon alpha-2b increases the cure rate in laser treated patients with multiple persistant genital

warts: a placebo controlled study. Genitourin Med 1991; 67: 99-102.

94. Zachariae H, Aslam H M, Bjerring P, Søgaard H, Zachariae E, Heickendorff L. Serum

aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: Relation to liver

fibrosis and arthritis. J Am Acad Derm 1991; 25: 50-53.

95. Heickendorff L, Parvez A, Bjerring P, Halkier-Sørensen L, Zachariae H. Serum aminoterminal

propeptide of type III procollagen in systemic sclerosis. Acta Derm Venereol (Stockh) 1991; 71:

185-188.

CV Peter Bjerring, Professor, MD, Dr.Sci

96. Andersen P H, Abrams K, Bjerring P, Maibach H. A time-correlation study of ultraviolet B-induced

erythema measured by reflectance spectropy and laser Doppler flowmetry. Photodermatol

Photomimmunol Photomed 1991: 8: 123-128.

97. Zachariae R, Bjerring P, Zachariae C, Arendt-Nielsen L, Nielsen T, Eldrup E, Larsen CS,

Gotliebsen K. Monocyte chemotactic activity in sera after hypnotically induced emotional states.

Scand J Immunol 1991; 34: 71-79.

98. Svensson P, Arendt-Nielsen L, Bjerring P, Kaaber S. Vertex potentials evoked by nociceptive laser

stimulation of oral mucosa: a comparison of four stimulation paradigms. Anesth Pain Control Dent

1992; 4: 222-228.

99. Nielsen J C, Arendt-Nielsen L, Bjerring P, Svensson P. The analgesic effect of EMLA-cream on

facial skin - Quantitative evaluation using argon laser stimulation. Acta Derm Venereol (Stockh)

1992; 72: 281-284.

100. Sindrup S M, Arendt-Nielsen L, Brøsen K, Bjerring P, Angelo H, Eriksen B, Gram sL F. The effect

of quinidine on the analgesic effect of codeine. Eur J Clin Pharmacol 1992; 42:587-592.

101. Svensson P, Bjerring P, Arendt-Nielsen L, Kaaber S. Hypoalgesic effect of EMLA and lidocaine gel

applied on human oral mucosa: Quantitative evaluation by sensory and pain thresholds to argon

laser stimulation. Anesth Prog 1992; 39: 4-8.

102. Nielsen J C, Bjerring P, Arendt-Nielsen L. Analgesic efficacy and plasma concentrations of

paracetamol in laser induced pain. Eur J Clin Pharmacol 1992; 42: 261-264.

103. Berardesca E, Andersen P H, Bjerring P, Maibach H I. Erythema induced by organic solvents: in

vivo evaluation of oxygenized and deoxygenized haemoglobin by reflectance spectroscopy.

Contact Dermatitis 1992; 27: 8-11.

104. Nielsen J C, Bjerring P, Arendt-Nielsen L and Petterson K-J. Analgesic efficacy of immediate and

sustained release paracetamol and plasma concentration of paracetamol. Double blind, placebo-

controlled evaluation using painful laser stimulation. Eur J Clin Pharmacol 1992; 42: 261-264.

105. Zachariae H, Bjerring P, Heickendorff L, Møller B, Wallevik K, Rook A H. Photopheresis and

systemic sclerosis. Arch Dermatol 1992; 128: 1651-1653.

106. Svensson P, Bjerring P, Arendt-Nielsen L, Kaaber S. Oral mucosal analgesia quantitiatively

assessed by single argon laser induced thresholds and pain-evoked vertex potentials. Anesth Pain

Control Dent 1993; 2: 154-161.

108. Zachariae R, Bjerring P. Increase and decrease of delayed cutaneous reactions obtained by

hypnotic suggestions during sensitization: Studies on dinitrochlorobenzene (DNCB) and

diphenylcyclopropenone (DCP). Allergy 1993; 48: 6-11.

109. Svensson P, Arendt-Nielsen L, Bjerring P, Kaaber S. Vertex potentials evoked by nociceptive laser

stimulation of oral mucosa: relationship to stimulus intensity. Anesth Pain Control Dent 1993; 2: 27-

33.

110. Zachariae R, Bjerring P. Laser-induced pain-related brain potentials and sensory pain ratings in

high and low hypnotizable subjects during hypnotic suggestions of relaxation, dissociated imagery,

focused analgesia and placebo. Int J Clin and Exp Hypnosis 1994; 17: 56-80.

111. Svensson P, Bjerring P, Arendt-Nielsen L, Kaaber S. Sensory and pain thresholds to orofacial

argon laser stimulation in patients with chronic burning mouth syndrome and control subjects. Clin

J Pain 1993; 9: 207-215..

112. Bjerring P. Comparison of the bioactivity of mometasone furoate fatty cream 0.1%, betamethasone

dipropionate 0.05% cream, and betamethasone valerate 0.1% cream in humans. - Inhibition of UV-

B induced inflammation monitored by laser Doppler blood flowmetry. Skin Pharmacology 1993; 6:

187-192.

CV Peter Bjerring, Professor, MD, Dr.Sci

113. van-der-Burght M, Schonemann NK, Laursen JK, Arendt-Nielsen L, Bjerring P. Duration of

analgesia following application of eutectic mixture of local anaesthetics (EMLA) on genital mucosa.

Acta Derm Venereol (Stockh) 1993:73; 456-458.

114. van-der-Burght M, Rasmussen S E, Arendt-Nielsen L, Bjerring P. Morphine does not affect laser

induced warmth and pin prick pain thresholds. Acta Anaesthest Scand 1994; 38: 161-164.

115. Petersen-Felix S, Arendt-Nielsen L, Bak P, Bjerring P, Breivik H, Svensson P, Zbinden A M.

Ondansetron does not inhibit the analgesic effect of alfentanil. Br J Anaesth 1994; 73: 326-330.

116. Zachariae H, Bjerring P, Heickendorff L, Møller B, Wallevik K, Angelo H. Photopheresis in systemic

sclerosis. Acta Derm Venereol 1993; 73: 356-361.

117. Heickendorff L, Zachariae H, Bjerring P, Halkier-Sørensen L. Plasma endothelin and antinuclear

antibodies in systemic sclerosis. Lancet, dec. 1993.

118. Øberg B, Arendt-Nielsen L, Bjerring P. Evaluation of intravenous regional anaesthesia using saline,

morphine, lidocaine or prilocaine. The International Monitor 1993: 19-12.

119. Zacheriae H, Heickendorff L, Bjerring P, Halkier-Sørensen L, Søndergaard K. Plasma Endothelin

and the Aminoterminal Propeptide of Type III Procollagen (PIIINP) in Systemic Sclerosis. Acta

Derm Venereol 1994; 74: 368-370.

120. Zachariae R, Øster H, Bjerring P. Effects of hypnotic suggestions on UVB-radiation induced

erythema and skin blood flow. Photodermatol Photoimmunol Photomed 1994: 10; 154-160.

121. Zachariae H, Bjerring P, Halkier-Sørensen L, Heickendorff L, Søndergaard K. Skin scoring in

systemic sclerosis: A modification - Relations to Subtypes and the Aminoterminal Propeptide of

Type III Procollagen (PIIINP). Acta Derm Venereol 1994; 74: 444-446.

122. van-der-Burght M, Schonemann NK, Laursen JK, Arendt-Nielsen L, Bjerring P. Onset and duration

of hypoalgesia following application of lidocaine spray on genital mucosa. Acta Obst Gyn Scand

1994;74: 444-446.

123. Zachariae H, Bjerring P, Brodthagen U, Søgaard H. Photopheresis in the Red Man or Pre-Sézary

Syndrome. Dermatology 1995; 190: 132-135.

124. Heickendorff L, Zachariae H, Bjerring P, Halkier-Sørensen L, Søndergaard K. The use of

serological markers for collagen synthesis and degradation in systemic sclerosis. J Am Acad

Dermatol 1995; 32: 584-588.

125. Steinmetz J, Bjerring P. Video-optical monitoring of wheal and flare reactions. Effects of topical Na-

sucrose-sulphate. Skin Research and Technology 1995; 1: 90-95.

126. Jensen B M, Bjerring P, Christiansen JS, Ørskov H. Gluceose content in human skin: relationship

with blood glucose levels. Scand J Clin Lab Invest 1995; 55: 427-432.

127. Arendt-Nielsen L, Petersen-Felix S, Fischer M, Bak P, Bjerring P, Zbinden A M. The effect of N-

Methyl-D-aspartate Antagonist (Ketamine) on Single and Repeated Nociceptive Stimuli: A

Placebo-Controlled Experinental Human Study. Anesth Analg 1995; 81:63-68.

128. Petersen-Felix S, Arendt-Nielsen L, Bak P, Roth D, Fischer M, Bjerring P, Zbinden A M. Analgesic

effect in humans of subanaesthetic isoflurane concentrations evaluated by experimentally induced

pain. Br J Anaesth 1995; 75: 55-60.

129. Larsson B, Egekvisk H, Bjerring P. Regional variations in skin perfousion and skin thickness may

contribute to varying efficacy of topical, local anaesthetics in neonates. Paediatric Anaesthesia

1996; 6: 107-110.

130. Zachariae H, Heickendorff L, Bjerring P. Plasma Endothelin in Posriasis - Possible Relation to

Therapy and Toxicity. Acta Derm Venereol 1996; 76:442-443.

CV Peter Bjerring, Professor, MD, Dr.Sci

131. Heidenheim M, Petersen CS, Bjerring P, Egekvist H. Laserbehandling i dermatologien. Månedsskr

Prakt Lægegern 1996; 74: 601-608.

132. Zachariae R, Øster H, Bjering P, Kragballe K. Effects of psychologic intervention on psoriasis: a

preliminary report. J Am Acad Dermatol 1996; 34: 1008-1015.

133. Zachariae H, Halkier-Sørensen L, Bjerring P, Heickendorff L. Treatment of ischaemic Digital Ulcers

and Prevention of Gangrene with Intravenous Iloprost in Systemic Slerosis. Acta Derm Venereol

(Stockh) 1996; 76: 236-238.

134. Thastum M, Zachariae R, Schøler M, Bjerring P, Herlin T. Cold pressor pain: Comparing

responses of juvenile arthritis patients and their parents. Scand J Rheumatol 1997; 26:272-279.

135. Andersen PE, Dam JS, Petersen PM, Bjerring P. Local Diffurse reflectance from three-layered skin

tissue structures. In: Optical Tomography and Spectroscopy of Tissue: Theory, Instrumentation,

Model, and Human Studies II. SPIE BiOS ´97 Proceedings, vol. 2979, 515-526.

136. Bjerring P, Zachariae H, Søgaard H. The Flashlamp-pumped Dye Laser and Dermabrasion in

Psoriasis - Further Studies on the Reversed Köbner Phenomenon. Acta Derm Venereol 1997; 77:

59-61.

137. Zachariae R, Jørgensen M M, Christensen S, Bjerring P. Effects of relaxation on the delaysed-type

hypersensitivity reaction to diphenylcyclopropenone (DCP). Allergy 1997; 52: 760-764.

138. Zachariae H, Bjerring P, Søndergaard K, Halkier-Sørensen L. Arbejdsbetinget systemisk

sklerodermi hos mænd. Ugeskrift for Læger, 1997; 159: 2687-2689.

139. Bjerring P. Two years' experience as a research professor in dermatological laser treatment and

laser-monitoring/diagnostics. Forum for Nord Derm Ven 1997; 2: 7-9.

140. Egekvist H, Bjerring P: Comparison off the analgesic effect of EMLAR cream and EMLAR patch on

normal skin evaluated with laser-induced pain stimuli. Acta Derm Venereol (Stockh) 1997; 77: 214-

6.

141. Zachariae H, Bjerring P, Lybecker H. Laser depilation using a free-running long pulse ruby laser.

Proceedings of the First International Meeting of the International Hair Research Society.

Melbourne, 1997,June 11-14.

142. Bjerring P, Zachariae H, Lybecker H, Clement M. Evaluation of the free running ruby laser for hair

removal. Acta Derm Venereol (Stockh) 1998; 678:48-51.

143. Clement M, Kiernan M, Bjerring P. L'epilation par laser rubis. Etude. Rapport udgivet af Laser Bleu

S. A., Nozay, France. 1998, 1-19.

144. Bjerring P, Egekvist H, Blake T. Comparison of the efficacy and safety of three different depilatory

methods. Skin Research and Technology 1998; 4: 196-198.

145. Egekvist H, Bjerring P. Effect of EMLA cream on skin thickness and subcutaneous venous

diameter. Proceedings of the 7th Congress of European Academy of Dermatology & Venereology,

October 1998, JEADV; 11 (Suppl 2): 261.

146. Egekvist H, Thestrup-Pedersen K, Bjerring P. Treatment of a subcutaneous painful keloid-like

formation monitored by high-frequency ultrasound. Proceedings of the 7th Congress of European

Academy of Dermatology & Venereology, October 1998, JEADV; 11 (Suppl 2): 261.

147. Sindrup S H, Nielsen J C, Bjerring P, Arendt-Nielsen L. Imipramine does not affect argon-laser-

induced pin-prick pain thresholds and laser-evoked cerebral potentials. European Journal of Pain

1998; 2: 127-132.

148. Bjerring P, Clement M, Gault D. Neue Studien zur Laser-Epilation. Kosmetik International 1998; 5:

54-56.

CV Peter Bjerring, Professor, MD, Dr.Sci

149. Zachariae R, Andersen O K, Bjerring P, Jørgensen M M, Arendt-Nielsen L. Effects of an opioid

antagonist on pain intensity and withdrawal reflexes during induction of hypnotic analgesia in high-

and low-hypnotizable volunteers. European Journal of Pain 1998; 2: 25-34.

150. Zachariae R, Jørgensen M M, Egekvist H, Bjerring P. Cutaneous reactions to histamine prick tests

after hypnotically induced emotions of anger, sadness, and happiness. Allergy 2001 Aug; 56(8):

734-40.

151. Zachariae R, Melchiorsen H, Frøbert O, Bjerring P, Bagger J P. Experimental pain and psychologic

status of patients with chest pain with normal coronary arteries or ischemic heart disease. Am

Heart J. 2001: 142; 63-71.

152 Zachariae H, Bjerring P. Laser treatment of hirsutism and hypertrichosis. In: Francisco Camacho

ed.: Hair Biology and Disorders. Martin Dunitz, 1999.

153 Nissen J B, Egekvist H, Bjerring P, Kragballe K: Effect of intradermal injection of methionine-

enkephalin on human skin. Acta Derm Venereol 1999:79:23-6.

154 Trezza M, Krogh K, Egekvist H, Bjerring P, Laurberg S: Bowel problems in patients with systemic

sclerosis. Scand J Gastroenterol 1999:34:409-13.

155 Egekvist H, Bjerring P, Arendt-Nielsen L: Pain and mechanical injury of human skin following

needle insertions. Eur J Pain 1999;3:41-9.

156 Regional variations in pain to controlled mechanical skin traumas from automatic needle insertions

and relations to ultrasonography. Skin Res Technol 1999;5:247-254.

157 Hædersdal M, Egekvist H, Efsen J, Bjerring P: Skin pigmentation and texture changes after hair

removal with the normal-mode ruby laser. Acta Derm Venereol 1999:79:465-8.

158 Mirz F, Zachariae R, Andersen SE, Nielsen AG, Johansen LV, Bjerring P, Pedersen CB. The low-

power laser in the treatment of tinnitus. Clin Otolaryngol 1999;24:346-354.

159 Zachariae H, Bjerring P, Lybecker H. Laser depilation using a free-running long pulse ruby laser.

Exp Dermatol 1999;8(4):301-302.

160. Bjerring P, Clement M, Heickendorff L, Egekvist H, Kiernan M. Selective non-ablative wrinkle

reduction by laser. J Cutan Laser Ther 2000;2:9-15.

161. Bjerring P, Cramers M, Egekvist H, Christiansen K, Troilius A. Hair reduction using a new intense

pulsed light irradiator and a normal mode ruby laser. J Cutan Laser Ther 2000;2:63-71.

162. Ipsen P, Egekvist H, Aksglaede K, Zachariae H, Bjerring P, Thommesen P. Oesophageal

manometry and video-radiology in patients with systemic sclerosis: a retrospective study of its

clinical value. Acta Derm Venereol 2000;80:130-3.

163. Haker E, Egekvist H, Bjerring P. Effect of sensory stimulation (acupuncture) on sympathetic and

parasympathetic activities in healthy subjects. J Auton Nerv Syst 2000;79:52-9.

164. Mirz F, Zachariae R, Andersen SE, Nielsen AG, Johansen LV, Bjerring P, Pedersen CB.

Behandling af tinnitus med lavenergi-laser. Ugeskr Læger 2000; 162: 3607-10.

165. Arendt-Nielsen L, Pedersen P, Poulsen P, Kæseler Andersen O, Bjerring P, Coste I, Insuasty J,

Sindrup S, Drewes A. A 5-HT antagonist (UP26-91) versus codeine and placebo in a human

experimental pain study. Pain Res Management 2000; 4: 135-140.

166. Zachariae R, Jørgensen M M, Bjerring P, Svendsen G. Autonomic and psychological responses to

an acute psychological stressor and relaxation: The influence of hypnotizability and absorption. Int

J Clin Exp Hypnosis 2000; 48: 388-403.

CV Peter Bjerring, Professor, MD, Dr.Sci

167. Zachariae R, Mirz F, Johansen L V, Andersen S E, Bjerring P, Pedersen C B. Reliability and

validity of a Danish adaptation of the Tinnitus Handicap Inventory. Scand Audiol 2000;29(1):37-43.

168. Bjerring P. Clinical comparison of hair reduction using the newest generation IPL and a first

generation ruby laser. J Cutan Laser Ther. 2000 Dec;2(4):211.

169. Bjerring P, Christiansen K. Intense pulsed light source for treatment of small melanocytic nevi and

solar lentigines. J Cutan Laser Ther. 2000 Dec;2(4):177-81.

170. Egekvist H, Bjerring P. Effect of EMLA cream on skin thickness and subcutaneous venous

diameter. A randomized, placebo-controlled study in children. Acta Derm Venereol. 2000 Sep-

Oct;80(5):340-3.

171. Zachariae R, Jorgensen M M, Egekvist H, Bjerring P. Skin reactions to histamine of healthy

subjects after hypnotically induced emotions of sadness, anger, and happiness. Allergy. 2001

Aug;56(8):734-40.

172. Zachariae R, Melchiorsen H, Frobert O, Bjerring P, Bagger J P. Experimental pain and psychologic

status of patients with chest pain with normal coronary arteries or ischemic heart disease. Am

Heart J. 2001 Jul;142(1):63-71.

173. Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial

telangiectasias. J Cosmet Laser Ther. 2001 Dec;3(4):169-73.

174. Bjerring P, Clement M, Heickendorff L, Lybecker H, Kiernan M. Dermal collagen production

following irradiation by dye laser and broadband light source. J Cosmet Laser Ther. 2002

Jun;4(2):39-43.

175. Pedersen J, Gao C, Egekvist H, Bjerring P, Arendt-Nielsen L, Gregersen H, Drewes AM. Pain and

biomechanical responses to distention of the duodenum in patients with systemic sclerosis.

Gastroenterology. 2003 May;124(5):1230-9.

176. Andersen P E, Thrane L, Bjerring P, Hougaard J L, Hansen P R. Optical coherence tomography.

Ugeskr Laeger. 2003 Apr 7;165(15):1546-50.

177. Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for the treatment of dye laser

resistant port-wine stains. J Cosmet Laser Ther. 2003 Apr;5(1):7-13.

178. Bjerring P, Christiansen K, Troilius A, Dierickx C. Facial photo rejuvenation using two different

intense pulsed light (IPL)wavelength bands. Lasers Surg Med. 2004;34(2):120-6.

179. Omi T, Bjerring P, Sato S, Kawana S, Hankins R, Honda M. 420 nm intense continuous light

therapy for acne. J Cosmet Laser Ther. 2004 Sep;6(3):156-62.

180 Bjerring P. Photorejuvenation – An overview. Med. Laser Appl. 2004;19:186-195.

181 Omi T, Kawana S, Sato S, Takezaki S, Honda M, Igarashi T, Hankins R W, Bjerring P, Thestrup-

Pedersen K. Cutaneous immunological activation elicited by a low-fluence pulsed dye laser. Br J

Dermatol. 2005 Dec;153 Suppl 2:57-62.

182 Arendt-Nielsen L, Egekvist H, Bjerring P. Pain following controlled cutaneous insertion of needles

with different diameters. Somatosens Mot Res. 2006 Mar-Jun;23(1):37-43.

183 de Leeuw J, Tank B, Bjerring P, Koetsveld S, Neumann M. Concomitant treatment of psoriasis of

the hands and feet with pulsed dye laser and topical calcipotriol, salicylic acid, or both: a

prospective open study in 41 patients. J Am Acad Dermatol. 2006 Feb;54(2):266-71.

184 Haedersdal M, Lomholt H B, Bjerring P, Egekvist H, Esmann J. Free versus non-free treatments

with laser and intense pulsed light in dermatology: distinguishing medical laser treatments to be

provided free of charge from cosmetic self-payment treatments. Ugeskr Laeger. 2005 Oct

24;167(43):4091-4.

CV Peter Bjerring, Professor, MD, Dr.Sci

185 Hedelund L, Bjerring P, Egekvist H, Haedersdal M. Ablative versus non-ablative treatment of

perioral rhytides. A randomized controlled trial with long-term blinded clinical evaluations and non-

invasive measurements. Lasers Surg Med. 2006 Feb;38(2):129-36.

186 Hedelund L, Due E, Bjerring P, Wulf H C, Haedersdal M. Skin rejuvenation using intense pulsed

light: a randomized controlled split-face trial with blinded response evaluation. Arch Dermatol. 2006

Aug;142(8):985-90.

187 Yeung C K, Shek SY, Bjerring P, Yu C S, Kono T, Chan H H. A comparative study of intense

pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in

Asian skin. Lasers Surg Med. 2007 Jan;39(1):1-6.

188 Christiansen K, Bjerring P, Troilius A. 5-ALA for photodynamic photorejuvenation - optimization of

treatment regime based on normal-skin fluorescence measurements. Lasers Surg Med. 2007

Apr;39(4):302-10.

189 Bjerring P, Egekvist H, Jacobsen P, Serup J. Topical retinoid penetrates intact human epidermis –

A suction blister study. European Dermatology, 2008;3:42-44.

190 Ash C, Town G, Bjerring P. Relevance of the structure of time-resolved spectral output to light-

tissue interaction using intense pulsed light (IPL). Lasers Surg Med. 2008 Feb;40(2):83-92.

191 Jørgensen T M, Tycho A, Mogensen M, Bjerring P, Jemec G B. Machine-learning classification of

non-melanoma skin cancers from image features obtained by optical coherence tomography. Skin

Res Technol. 2008 Aug;14(3):364-9.

192 Christiansen K, Bjerring P. Low density, non-ablative fractional CO2 laser rejuvenation. Lasers

Surg Med. 2008 Sep;40(7):454-60.

193 Roosen G F, Westgate G E, Philpott M, Berretty P J, Nuijs T A, Bjerring P. Temporary hair removal

by low fluence photoepilation: histological study on biopsies and cultured human hair follicles.

Lasers Surg Med. 2008 Oct;40(8):520-8.

194 de Leeuw J, van der Beek N, Neugebauer W D, Bjerring P, Neumann H A. Fluorescence detection

and diagnosis of non-melanoma skin cancer at an early stage. Lasers Surg Med. 2009

Feb;41(2):96-103.

195 de Leeuw J, de Vijlder H C, Bjerring P, Neumann H A. Liposomes in dermatology today. J Eur

Acad Dermatol Venereol. 2009 May;23(5):505-16. Epub 2009 Jan 23.

196 Bjerring P, Christiansen K, Troilius A, Bekhor P, de Leeuw J. Skin fluorescence controlled

photodynamic photorejuvenation (wrinkle reduction). Lasers Surg Med. 2009 Jul;41(5):327-36.

197 Togsverd-Bo K, Gluud C, Winkel P, Larsen H K, Lomholt H B, Cramers M, Bjerring P, Haedersdal

M. Paring and intense pulsed light versus paring alone for recalcitrant hand and foot warts: a

randomized clinical trial with blinded outcome evaluation. Lasers Surg Med. 2010 Feb;42(2):179-

84.

198 de Leeuw J, van der Beek N, Bjerring P, Neumann H A. Photodynamic therapy of acne vulgaris

using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with

topical keratolytic agents. J Eur Acad Dermatol Venereol. 2010 Apr;24(4):460-9.

199 de Leeuw J, Assen Y J, van der Beek N, Bjerring P, Neumann H A.

Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof

transplantation. J Eur Acad Dermatol Venereol. 2011 Jan;25(1):74-81.

200 Bjerring P, Christiansen K. Facial Rejuvenation and Other Clinical Applications of Intense Pulsed

Light. In: Raulin and Karsai eds: Laser and IPL Technology in Dermatology and Aesthetic

Medicine: SpringerLink 2011.

201 Bjerring P, Christiansen K: Fluorescence-guided Photodynamic Therapy. In: Gold M, Ed:

Photodynamic Therapy in Dermatology, Springer Science + Business Media LLC, 2011

CV Peter Bjerring, Professor, MD, Dr.Sci

202 Town G, Ash C, Dierickx C, Fritz K, Bjerring P, Haedersdal M. Guidelines on

the safety of light-based home-use hair removal devices from the European Society for Laser

Dermatology. J Eur Acad Dermatol Venereol. 2012 Jul;26(7):799-811.

203 van der Beek N, de Leeuw J, Demmendal C, Bjerring P, Neumann H A. PpIX

fluorescence combined with auto-fluorescence is more accurate than PpIX

fluorescence alone in fluorescence detection of non-melanoma skin cancer: An

intra-patient direct comparison study. Lasers Surg Med. 2012 Apr;44(4):271-6

204 Thaysen-Petersen D, Bjerring P, Dierickx C, Nash J F, Town G, Haedersdal M. A systematic

review of light-based home-use devices for hair removal and considerations on human safety. J

Eur Acad Dermatol Venereol. 2012 May; 26(5):545-53

205 Hedelund L, Haak C S, Togsverd-Bo K, Bogh MK, Bjerring P, Haedersdal M. Fractional CO2 laser

resurfacing for atrophic acne scars: a randomized controlled trial with blinded response evaluation.

Lasers Surg Med. 2012 Aug;44(6):447-52

206 Espelund U, Søndergaard K, Bjerring P, Flyvbjerg A, Frystyk J. Interstitial fluid contains higher in

vitro IGF bioactivity than serum: a study utilizing the suction blister technique. Growth Horm IGF

Res. 2012 Dec;22(6):234

207 Christiansen K, Drosner M, Bjerring P. Optimized settings for Nd:YAG laser treatments of leg

telangiectasias. J Cosmet Laser Ther. 2015 Apr;17(2):69-76.

208 Town G, Ash C, Dierickx C, Fritz K, Bjerring P, Haedersdal M. Guidelines on the safety of light-

based home-use hair removal devices from the European Society for Laser Dermatology. J Eur

Acad Dermatol Venereol. 2012 Jul;26(7):799-811.

209 Espelund U, Søndergaard K, Bjerring P, Flyvbjerg A, Frystyk J. Interstitial fluid contains higher in

vitro IGF bioactivity than serum: a study utilizing the suction blister technique. Growth Horm IGF

Res. 2012 Dec;22(6):234-9.

210 van der Beek N, Bjerring P, Neumann H A. The choice and measurement of fluence in

photodynamic therapy for superficial basal cell carcinoma. Br J Dermatol. 2015 Oct;173(4):1105-6.

211 Mikkelsen CS, Holmgren H R, Borch J E, Bandier J, Bjerring P, McDermott D A. Benign acute

childhood myositis (BACM). Månedsskrift for Almen Praksis nr 10, oktober 2015: 857-860.

212 Mikkelsen C S, Holmgren H R, Bjerring P, Borch J E. Infantile Hæmangiomer – what to do?

Månedsskrift for Almen Praksis oktober 2015.

213 van der Beek N, Donne K, Bjerring P, Neumann H A. The effect of pulse train profile on the

efficacy of pulsed-dye laser treatments for port-wine stains. Br J Dermatol. 2015 Nov;173(5):1341-

3.

214 Mikkelsen CS, Holmgren HR, Borch JE, Bandier J, Lohrentzen H, Bjerring P. Syfilis (lues) i

sekundært stadie hos kvinde. Månedsskrift for Almen Praksis nr 11, november 2015: 927-932.

215 Mikkelsen C S, Holmgren H R, Bjerring P. Rosacea. Månedsskrift for Almen Praksis, January

2015.

216 Philipp-Dormston W G, Sanclemente G, Torezan L, Tretti Clementoni M, Le Pillouer-Prost A,

Cartier H, Szeimies R M, Bjerring P. Daylight photodynamic therapy with MAL cream for large-

scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an

international expert group. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):8-15.

217 Town G, Bjerring P. Is paradoxical hair growth caused by low-level radiant exposure by home-use

laser and intense pulsed light devices? J Cosmet Laser Ther. 2016 May 9:1-8.

CV Peter Bjerring, Professor, MD, Dr.Sci

218 Mikkelsen C S, Holmgren H R, Bandier J, Borch J, Bjerring P, Sepehri M, Carlsen KH, Serup J.

Problemtatoveringer – en introduktion for praktiserende læger. Månedsskrift for Almen Praksis nr

4, april 2016: 329-343.

219 Mikkelsen CS, Holmgren H R, Kjellman P, Heidenheim M, Kappinnen A, Bjerring P, Huldt-Nystrøm

Theis. Rosacea: a clinical review. Dermatology Reports 2016; 8:6387

220 Mikkelsen C S, Holmgren H R. Pseudo købners fænomen efter forbrænding. Månedsskrift for

Almen Praksis March, 2016

221 Mikkelsen C S, Holmgren H R, Bjerring P, Seefeldt T. Ti skarpe om sommerens plager, del 1.

Månedsskrift for Almen Praksis, June, 2016

222 Dal J, Høyer K L, Pedersen S B, Magnusson N E, Bjerring P, Frystyk J, Møller N, Jessen N, Lunde

Jørgensen J O. Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus

Somatostatin Analog Treatment. J Clin Endocrinol Metab. 2016 Oct;101(10):3716-3723.

223 Ramshanker N, Aagaard M, Hjortebjerg R, Voss T, Møller N, Lunde Jørgensen J O, Jessen N,

Bjerring P, Magnusson N, Oxvig C, Bjerre M, Frystyk J. Effects of prednisolone on serum and

tissue fluid IGF-I receptor activation and post-receptor signaling in humans. J Clin Endocrinol

Metab. 2017;102:4031-4040.

224 Mikkelsen C S, Holmgren H R, Borch J, Stangeland K Z, Kjellmann P, Nielsen C, Bjerring P.

Aktiniske keratoser og fotodynamisk terapi – en opdatering. Månedsskrift for almen praksis, 2016

June.

225 Bandier J, Holmgren HR, Borch J, Bjerring P, Mikkelsen C S: Guldinduceret erosiv oral lichen

ruber. Månedsskrift for almen praksis, 2017, January.

226 Mikkelsen C S, Holmgren H R, Nissen C, Borch J, Bjerring P. Basalcellehudkræft – en nødvendig

update. Månedsskrift for Almen Praksis, 2017, Februrary

227. Mikkelsen C S, Bjerring P, Lirvall M, Svensson M, Holmgren H R, Salava A, Huldt-Nystrøm T.

Rosacea: Time for a new approach. Forum for Nord Derm Ven 2017; 22: 3-12.

228. Mikkelsen C S, Pedersen K R, Bjerring P. Aknebehandling med begrænset brug af antibiotika.

Månedsskrift for Almen Praksis, 2018, April.

229. Mikkelsen C S, Ringe-Holmgreen H, Bjerring P, Schroeder S M, Schmidt L. Behandling af atopisk

dermatitis. Månedsskrift for Almen Praksis, 2018, May.

230. Mikkelsen C S, Ringe-Holmgreen H, Bjerring P, Schroeder SM, Schmidt L. Atopisk dermatitis -

lokalisation og ætiologi. Månedsskrift for Almen Praksis, 2018, May.

231. Mikkelsen C S, Penninga L, Arvesen K B, Bjerring P. Cutaneous manifestations in Health Care

Workers fighting Corona COVID-19 infection. Best Practice. 2020, April.

232. Mikkelsen C S, Arvesen K B, Bjerring, P. First observations on skin manifestations of Coronavirus

COVID-19 infection". Cutaneous manifestation in patients with Corona CoViD-19. Best Practice.

2020, April.

234. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Review Coronavirus COVID-19 and

Relevance for Dermatologists -Are We Ready for the Battle? 2020, April.

235. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Aurikulært vedhæng. Best Practice Nordic,

2020, March.

237. Mikkelsen C S, Arvesen, K B, Penninga L, Bjerring P. Dermato-Venereology in the Nordic

Countries Background. 2019, August.

238. Mikkelsen C S, Arvesen K B, Bjerring P, Penninga L. Artificial Intelligence in Dermatology - A

Systematic Review. Bidrag til tidsskrift, Forum for Nordic Dermato-Venereology. 2019.

CV Peter Bjerring, Professor, MD, Dr.Sci

239. Mikkelsen C S, Rømer-Mechlenborg K, Bjerring P, Penninga L. Case Report BHT finale version.

Forum for Nordic Dermato-Venerology. 2019 (2).

240. Eruptive Sebaceous Hyperplasia

241. Mikkelsen C S, Arvesen K B, Brendborg J, Bjerring P. Aurikulært vedhæng. Best Practice Nordic,

Dermal cylindroma. December 2018

242. Mikkelsen C S, Arvesen, K B, Bjerring P. Psoriasis, co-morbiditet og screening - eller mangel på

samme. 2018, December.

243. Lyengar S, Nouri K, Bjerring P et al.. Intense Pulsed Light (IPL): In book: Lasers in Dermatology

and Medicine. 2018, September.

244. Mikkelsen C S, Bjerring P, Arvesen K B, McDermott D A. Benign Acute Childhood Myositis

(BACM) – Two Incidents in the Same Patient. Forum for Nordic Dermato-Venerology 23 (2). 2018,

September.

245. Mikkelsen C S, Arvesen K B, Bjerring P, Penninga L. Atopisk dermatitis – ny forståelse af

sygdommen. 2018, August.

246. Mikkelsen C S, Brendborg J, Penninga L, Arvesen K B, Bjerring P. Merkelcelle karcinom Best

Practice Nordic, 2018 , August.

247. Mikkelsen C S, Brendborg J, Penninga L, Arvesen K B, Bjerring P. Oral fokal epitelial hyperplasi.

Best Practice Nordic, 2018, August.

248. Mikkelsen C S, Ringe-Holmgren H, Bjerring P et al. Behandling af atopisk dermatitis. 2018, May.

249. Mikkelsen C S, Bjerring P, Ringe-Holmgren H, Schrøder S M, Schmidt L. Atopisk dermatitis –

lokalisation og ætiologi. Best practice. 2018, May.

250. Mikkelsen, C S, Pedersen K R, Bjerring P. Aknebehandling med begrænset brug af antibiotika.

2018, April.

251. Borch, J E, Mikkelsen C S, Ringe-Holmgren H, Bjerring P et al. Bliv klogere på spinocellulær

carcinom. 2017, November.

252. Mikkelsen C S, Arvesen K B, Holmgren H R, Bjerring P. Benign Acute Childhood Myositis (BACM)

– two incidents in the same patient. 2017, October.

253. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Aurikulært vedhæng – accessoriske tragi.

Best Practice Nordic. 2020, March.

254. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Children with Kawasaki-like symptoms could

possibly be related to COVID-19. Best Practice Nordic. 2020, May.

255. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Coronavirus COVID-19 and Relevance for

Dermatologists – Are We Ready for the Battle? Forum for Nordic Dermato-Venereology, Bind 25.

Nr. 1. 2020, p.1-3.

256. Borch L, Thorsteinsson K, Warner T C, Mikkelsen C S, Bjerring P, Lundbye-Christensen S,

Arvesen K B, Hagstroem S. COVID-19 reopening causes high risk of irritant contact dermatitis in

children. Danish Medical Journal, Bind 67, Nr. 9, A05200357, 2020, August.

257. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Cutaneous manifestations in Health Care

Workers fighting the current COVID-19 infection. Best Practice Nordic. 2020, April.

258. Arvesen K B, Penninga L, Palmqvist D F, Dahl K W, Bjerring P, Mikkelsen C S. Erythema

Multiforme-like Eruption in a Teenager Suspected with COVID-19 Infection. Forum for Nordic

Dermato-Venereology. Bind 25, Nr. 2, 2020 p.10-11.

CV Peter Bjerring, Professor, MD, Dr.Sci

259. Mikkelsen C S, Arvesen K B, Bjerring P. First Observations: Skin Manifestations of COVID-19

Infection. Best Practice Nordic. 2020, April.

260. Petersen S B, Arvesen K B, Penninga L, Mikkelsen C S, Bjerring P. Hand Sanitation and the

COVID-19 Pandemic. Forum for Nordic Dermato-Veneology, Bind 25, Nr. 2, 2020, p.16-17.

261. Penninga L, Arvesen K B, Bjerring P, Mikkelsen C S. Is COVID-19 a sexually transmitted disease

and how does the COVID-19 Pandemic Affect Sexually Transmitted Diseases? Forum for Nordic

Dermato-Venerology, Bind 25, Nr. 2. 2020. p. 14-15.

262. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Is Excessive Hand Hygiene during the

COVID-19 Pandemic Causing an Increase in Hand Eczema in Denmark? Best Practice Nordic.

2020, May.

263. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Maskne og anvendelsen af mundbind i

forbindelse med COVID-19. Best Practice Nordic, 2020, September.

264. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Non-Melanoma Skin Cancer (NMSC) –

Introduction. Best Practice Nordic. 2020, April.

265. Mikkelsen C S, Arvesen K B, Penninga L, Ternowitz T, Bjerring P. Prurigo Nodularis. Forum for

Nordic Dermato-Venerology, Bind 25, Nr. 2, 2020 p. 7-9.

266. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Secondary (acquired) Knuckle Pads. Best

Practice Nordic, Bind 8, Nr. 3, 2020, June, p. 22-23.

267. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. Sociale medier og dermatologi – inklusive

Coronavirus COVID-19. Best Practice Nordic, 2020, April.

268. Arvesen K B, Penninga L, Bjerring P, Mikkelsen C S. Teledermatology and COVID-19. Forum for

Nordic Dermato-Venerology, Bind 25, Nr. 2, 2020, p. 12-13.

269. Mikkelsen C S, Arvesen K B, Penninga L, Bjerring P. The COVID-19 Pandemic: Are our

Dermatologica Patients on Immunomodulating Medication at High-risk?. Best Practice Nordic,

2020, April.

270. Penninga L, Arvesen K B, Bjerring P, Mikkelsen C S. The COVID-19 Pandemic and Immunological

Phenomena: Risk Assessent for Patients on Immunosuppressive and Immunomodulating

Medication. Forum for Nordic Dermato-Venerology, Bind 25, Nr. 2, 2020, p. 2-6.

271. Bjerring P, Petersen SB, Mosegaard ML. I2 PL—What is it and what does it mean? Dermatological

Reviews. 2020;1‐8. https://doi.org/10.1002/der2.48

CV Peter Bjerring, Professor, MD, Dr.Sci

4: Patents:

1:

US05164394: Method for treating hyperproliferative skin diseases

2:

US05021422: Method and composition for treating hyperproliferative skin diseases using 6-

aminopurine cytokinins

3:

EP 2 131 862 B1: Fluid photosensitizer for therapeutic photodynamic skin treatment and its use in

non therapeutic photodynamic skin treatments

4:

US Patent 7,252,628: Device for treating human skin by means of radiation

RAM Van Hal, BLG Bakker, ME Roersma, P Bjerring

5:

US Patent App. 12/530,264

Method for non-therapeutic or therapeutic photodynamic skin treatment

K Christiansen, P Bjerring, K Van Der Beek

5: Book Chapters:

Lærebog i Dermato-venerologi, Eds: K. Thestrup-Pedersen, KE Andersen and H Zachariae, Munksgaard,

Copenhagen, 1993.

In Vivo Examination of the Skin: A Handbook of Non-invasive Methods,

Eds.: J Serup and GBE Jemec, Chapter 7.1, CRC Press, Florida, USA, 1994.

In Vivo Examination of the Skin: A Handbook of Non-invasive Methods, Eds.: J Serup and GBE Jemec,

Chapter 18.2, CRC Press, Florida, USA 1994.

Laser treatment. In: Hair and its disorders. Biology, pathology and management. Chapter, pages 383-390.

Eds.: Francisco M Camacho, Valerie A Randall, Vera H Price. Martin Dunitz ltd, London 2000, ISBN 1-

85317-799-7.

Laser and IPL Technology in Dermatology and Aesthetic Medicine.

C. Raulin and S. Karsai (eds.), Chapter Chapter 5: Facial Rejuvenation and Other

Clinical Applications of IPL. DOI: 10.1007/978-3-642-03438-1_5, © Springer-Verlag Berlin Heidelberg 2010

CV Peter Bjerring, Professor, MD, Dr.Sci

6: Congress Contributions - Oral Presentations:

l. PUVA treatment of alopecia areata. P. Bjerring & J. Celis. Niels-Steensen-Symposium, 15th

meeting, Åbenrå, November 1982.

2. Selenium protects mice against the acute effects of UV-light. E.B. Thorling, K. Overvad & P.

Bjerring. 12 th Linderstrøm-Lang Conference, Langevatn, Island, June 1982.

3. Occupational hypopigmentation following rubber grinding. P. Bjerring. Niels-Steensen-Symposium,

16th meeting. Timmendorfer Strand, April 1983.

4. Elasticitetsmålinger og måling af hudtykkelser ved sclerodermi. P. Bjerring. Dansk Dermatologisk

Selskab, 66. møde, May 1983.

5. Retrovirus ved mycosis fungoides. K. Thestrup-Pedersen, K. Kaltoft, S. Bisballe, J. Jensen, P.

Bjerring & H. Zachariae. Dansk Dermatologisk Selskab, 688. møde.

6. Leverbiopsi ved tigasonbehandling. E. Foged, P. Bjerring, K. Kragballe, H. Zachariae & H.

Søgaard. Dansk Dermatologisk Selskab, 688. møde, May 1983.

7. Behandling af svær acne hos kvinder med Diane (cyproteronacetat og etinyløstradiol). P. Bjerring.

H. Zachariae & J. Eggert. Nordisk Dermatologisk Forenings XXXIII Kongres, Oslo, 12.-16. June,

1983.

8. Etablering og præliminær karakterisering af cellelinier fra kutane lymfomer. K. Kaltoft, S. Bisballe,

P. Bjerring & K. Thestrup-Pedersen. Nordisk Dermatologisk Forenings XXIII Kongres, Oslo, 12.-16.

June, 1983.

9. Laserbehandling og fotoaktive stoffer i dermatologien. P. Bjerring, H. Zachariae & P. Ebbesen.

Nordisk Dermatologisk Forenings XXIII Kongres, Oslo, 12.-16. June, 1983.

10. Leverbiopsi under etretinate behandling. E.K. Foged, P. Bjerring, K. Kragballe, H. Søgaard & H.

Zachariae. Nordisk Dermatologisk Forenings XXIII Kongres, Oslo, 12.-16. June, 1983.

11. Laserbehandling af naevus flammeus. P. Bjerring. Foreningen af Jyske Dermatologer, Esbjerg.

October, 1983.

12. Skin elasticity (dynamic impedance measurements) in scleroderma. P. Bjerring. Niels-Steensen-

Symposium 17th meeting. October, 1983.

13. Laserteknologi og teori ved argonlaserbehandling. P. Bjerring. Århus Kommunehospital,

November, 1983.

14. Liver biopsy during etretinate (tigason) treatment. H. Zachariae, E.K. Foged, P. Bjerring, K.

Kragballe & H. Søgaard. Retinoid Symposium, London, May, 1983.

15. Liver biopsies and tigason treatment. H. Zachariae, E.K. Foged, P. Bjerring, K. Kragballe & H.

Søgaard. Retinoid Symposium, Basel, 18.20. September, 1983.

16. Wiscott-Aldrich Syndrom behandlet med sandoglobulin. P. Bjerring & J. Ellegaard. Sandoz

symposium, København, October, 1983.

17. Selen og hudcancer. P. Bjerring, H.I. Beck, K. Overvad & E.B. Thorling. Risø, February, 1984.

18. Selen og psoriasis. P. Bjerring. H. I. Beck, K. Overvad & E.B. Thorling. Risø, February, 1984.

19. Naevus flammeus - behandling med laser. P. Bjerring og E.K. Foged. Foreningen af yngre

hospitalslæger, Århus, October, 1984.

CV Peter Bjerring, Professor, MD, Dr.Sci

20. Forebyggelsen af hudproblemer i fiskeindustrien. P. Bjerring. Arbejdsmiljøfondet, Esbjerg,

November, 1984.

21. Præliminære resultater af lokal behandling af psoriasis med methotrexate. Hotel Scandinavia,

København, April, 1985. Arrangør: Pharmacia A/S.

22. Laser therapy in Dermatology, clinical experience and practical demonstrations. P. Bjerring, E.K.

Foged & H. Zachariae, Århus June, 1985.

23. Spectral reflectance of human skin. P.H. Andersen & P. Bjerring. Niels-Steensen-Symposium,

Åbenrå, October, 1985.

24. Smerterelaterede evocerede potentialer. Lars Arendt-Nielsen & P. Bjerring. Dansk Medicoteknisk

Selskab, Ålborg Universitetscenter, April, 1986.

25. Somatosensory evoked potentials and perception. Arendt-Nielsen L, Bjerring P. III International

Evoked Potential Symposium. Berlin, P35, S.67, 1986.

26. Husstøvmider og atopisk dermatitis. Hans-Iver Beck & Peter Bjerring. Dansk Dermatologisk

Selskab, May 1986.

27. Photomedicin. Kemisk Forening, H.C. Ørsteds Instituttet, Københavns Universitet May 28th.1986.

28. Monitoring of skin disease by reflectance spectrophotometry. Klinikum der Christian-Albrecht-

Universitet Kiel, September 12th 1986.

29. Dermatologisk laserbehandling. Dansk Selskab for Laserterapi, København, February 22nd. 1986.

30. Photodynamisk Terapi. Kræftforskningsinstituttet, Århus. Arrangør: Kræftens Bekæmpelse.

April 2nd 1986.

31. Hudens optik. 24. Nordiske Dermatolog Kongres, Uppsala. 8.-11. June, 1986.

32. Dermatologisk laserbehandling. Nordiske Dermatolog Kongres, Uppsala. 8-11. June, 1986.

33. Dermatologisk laserbehandling af pigmenter i huden. Arbejdsmiljøinstituttet, København,

September 12, 1986.

34. Laser treatment of dermatological diseases. Warszawa. 25.-28. September, 1986.

35. Hospitalstrykluft, - en medicinsk specialitet. Danske Hospitalsmaskinmestres årskursus. 19.

September, 1986.

36. A new technique for quantitated pain measurement. Inter-collegiate Lectures in Neurophysiology,

Central Middlesex Hospital, London. Lars Arendt-Nielsen, Peter Bjerring. December 1986.

37. Cortical responses evoked by pain stimuli. Cost 13 miniseminar, Artificial Intelligence in Medical

Science. Lars Arendt-Nielsen & Peter Bjerring. Aalborg Universitetscenter, October 1986.

38. Hereditary haemorrhagic teleangiectasia treated by laser surgery. Peter Illum & Peter Bjerring.

Amsterdam, 6.-8. November, 1986.

39. Methotrexate inhibits the human C5a induced skin response in psoriasis patients. Thomas

Ternowitz, Peter Bjerring, Peter H. Andersen, Jens-M. Schrøder & Knud Kragballe. 17th Meeting of

the European Society for Dermatological Research. Amsterdam, 29. March.-1. April,1987.

40. Objektiv smertemåling. Dansk Medicoteknisk Selskab, Rigshospitalet, København. Peter Bjerring

& Lars Arendt-Nielsen. March 1987.

41. Kvantitativ smertemåling. Weekendseminar 'Smerte og smertebehandling' Aalborg

Folkeuniversitet, Aalborg. Lars Arendt-Nielsen & Peter Bjerring. March 1987.

CV Peter Bjerring, Professor, MD, Dr.Sci

42. Quantitative assessment of pain. Seminar on myofascial pain and dysfunction. Peter Bjerring &

Lars Arendt-Nielsen. Dansk Selskab for manuel medicin, Scanticon. Århus, 26 April 1987.

43. The analgetic effect of epicutaneous lidocain/prilocaine (EMLA) evaluated by sensory and pain

thresholds. Peter Bjerring & Lars Arendt-Nielsen. ESRA-VIth annual Meeting of the European

Society of Regional Anaesthesia. Paris, 7.-9. May 1987.

44. Evaluation of local analgetics by pain related cortical responses. Lars Arendt-Nielsen & Peter

Bjerring. VIth Annual Meeting of the European Society of Regional Anaesthesia. Paris, 7.-9. May,

1987.

45. Pre-pain and pain related evoked potentials elicited by laser pulses. 8. International congress of

Electromyography and related Clinical Neurophysiology, Sorrento, Italien, 1987. Arendt-Nielsen, L.

and Bjerring, P.

46. Evaluation of local analgetics by pain related cortical responses. Bjerring P, Arendt-Nielsen L. 8.

International Congress of Electromyography and related Clinical Neurophysiology, Sorrento,

Italien, 1987.

47. Human plasma fibronectin levels during ageing, cancer and some age-related diseases. Pardeep

Bhatia, Lars M. Rasmussen, Peter Bjerring, Suresh I.S. Rattan & Brian F. C. Clark. Second

International Congress of Biomedical Gerontology. Hamburg, 15.-17. July 1987.

48. Objective registration of cutaneous pain and the influence of local anaesthesia. III Dermatological

Reserarch Meeting, Århus, 18. September, 1987.

49. Economical aspects of dermatological laser treatments. I. Meeting of the Scandinavian Society for

Laser Therapy. København, 1.-4. October 1987.

50. Argon laser treatment of connective tissue diseases. I. Meeting of the Scandinavian Society for

Laser Therapy. Hugh Zachariae, Peter Bjerring & Marie Cramers. København, 1.-4. October, 1987.

51. Argon laser treatment of haemangioma capillare and teleangiectasia. I. Meeting of the

Scandinavian Society for LaserTherapy. Marie Cramers, Peter Bjerring & Hugh Zachariae.

København, 1.-4. October 1987.

52. Argon laser induced pain for quantitative evaluation of local analgesia. I. Meeting of the

Scandinavian Society for Laser Therapy. Lars Arendt-Nielsen & Peter Bjerring. København, 1.-4.

October 1987.

53. Somatosensory evoked potentials and perception. Arendt-Nielsen L, Bjerring P, 3nd International

evoked potential symposium, Berlin, P35, S.67 1986.

54. Laserbehandling of Morbus Osler. Dansk Oto-laryngologisk Selskab. Peter Illum & Peter Bjerring,

København, 7. November 1987.

55. Objektiv monitorering af laser induceret smertestimulation. Anæstesiologisk

smertebehandlingssymposium, Århus, November 1987.

56. Registrering af hjernens elektriske aktivitet (evoked potentials) som svar på smertestimulation med

laser. Smerte og smertebehandling, Ålborg Sygehus Syd,12. April 1987.

57. Laser evoked cerebral potentials in pain research. University of Washington, Seattle. Arendt-

Nielsen L, Bjerring P. November 1987.

58. Lasere - principper og medicinske anvendelsesområder. Peter Bjerring og Lars Arendt-Nielsen.

Staff meeting anæstesiologisk afd., Århus Kommunehospital, 3. December 1987.

59. Metode til objektiv kvantificering af smerter. Peter Bjerring & Lars Arendt-Nielsen. Dansk selskab

for manuel medicin, årsmøde, Århus, 5. March 1988.

CV Peter Bjerring, Professor, MD, Dr.Sci

60. A new quantitative method for measuring the mechanical properties of human skin. Niels-

Steensen-Symposium, Malente. Bjerring P, Arendt-Nielsen L. March 1988.

61. Objektiv smerteregistrering. Colloqium, Aarhus Amtssygehus. Bjerring P, Arendt-Nielsen L. May

1988.

62. Nye teknikker til kvantitativ måling af smerte under anæstesi. Staff-meeting, Aarhus Amtssygehus.

Arendt-Nielsen L., Bjerring P. May 1988.

63. Atopic dermatitis and the indour climate. III International Symposium on Atopic Dermatitis. Oslo, 1.

June 1988.

64. Hud-laser interaction. Dansk Optisk Selskabs Seminar, nr. 4. Århus, 19. May 1988.

65. Argon laser stimuleret objektiv smertemåling. Dansk Optiks Selskabs Seminar, nr. 4. Århus. Lars

Arendt-Nielsen & Peter Bjerring. 19. May 1988.

66. Fotodynamisk cancerbehandling, principper og metode. Dansk Optisk Selskab Seminar, nr. 4.

Århus, 19. May 1988.

67. In vivo reflektansspektrofotometri af hud. Dansk Optisk Selskabs Seminar, nr. 4. Århus. Peter H.

Andersen & Peter Bjerring. 19. May 1988.

68. Argonlaser behandling i dermatologien. Efteruddannelseskursus. Forening af Praktiserende jyske

Dermatologer. Munkebjerg, 9.-10. April 1988.

69. Kvantitativ, dynamisk sensorisk og smertemonitorering. Astra Møde, Sødertalje. Peter Bjerring &

Lars Arendt-Nielsen. 14. April 1988.

70. EMLA creme til overflade analgesi, metode og applikationsstudier. 173. Gentofte møde. Peter

Bjerring & Lars Arendt-Nielsen. 20. April 1988.

71. 15-HETE specifically inhibits the LTB4-induced inflammatory skin response. 18th Meeting of the

European Society for Dermatological Research. Ternowitz T, Andersen P H, Bjerring P, Fogh K,

Schrøder J-M, Kragballe K. München 19.-22. June 1988.

72. Tumour dose-response relationship to photofrin II and light energy delivered by a diffuse-light

irradiator. International Conference on Photodynamic Therapy and Medical Laser Applications.

London. Jens Winther & Peter Bjerring. 19.-21. July 1988.

73. The pharmacokinetics of weak analgetics (paracetamol) evaluated by pain related cortical

responses elicited by argon laser stimulation. The 7th congress of the international society electro-

physiological kinesiology. Enschede, Holland. Arendt-Nielsen L, Bjerring P. June 1988.

74. Quantification of A-delta and C. fiber pain in humans. Dept of Neurology, University Hospital,

Arendt-Nielsen L. Bjerring P.

75. New aspects in local anaesthesia. French-Danish Dermatology meeting, Hospital St. Louis, Paris,

Bjerring P, Arendt-Nielsen L. 29. September - 2. October 1988

76. Modulation of the type I immediate and type IV delayed immunoreactivity using direct suggestion of

Hypnosis. Adelaide, Australia. 4.-10. September 1988.

77. Quantitative inhibition of human exon reflexes by epicutaneous application of capsaicin and local

analgetics. Annual Meeting of the Society for neuroscience. Toronto, 13.-18. November 1988.

78. Nye metoder til kvantitativ smertemåling. Lars Arendt-Nielsen & Peter Bjerring. Dental, Vejle, 7.-9.

October 1988.

79. Måling af smerter. MEDIF uddannelse, Smertekursus. Scanticon, Kolding. Bjerring P, Arendt-

Nielsen L. 6. October 1988.

CV Peter Bjerring, Professor, MD, Dr.Sci

80. Neurofysiologisk anvendelse af laser stimulation. Klinisk Neurofysiologisk afd., Aarhus

Kommunehospital. Arendt-Nielsen L, Bjerring P. 19. January 1989.

81. Kløens patofysiologi. Dansk Allergologisk Selskab, Aarhus. Bjerring P, Arendt-Nielsen L. January

1989.

82. Manglende effekt af lokalanæstesi hos Ehlers Danlos patienter. Dansk Selskab for Manuel

Medicin, Aalborg. Kaalund S, Høgså B, Arendt-Nielsen L. Bjerring P. 15. February 1989.

83. Modulation of type I and IV skin reactions by hypnosis and guided suggestion. Dansk

Dermatologisk Selskab, Årsmøde, Aarhus. Zachariae B, Bjerring P, Arendt-Nielsen L. 6. May 1989.

84. First and second pain related cortical responses evoked by argon laser stimulation. 13 th Annual

Meeting of The Scandinavian Association for the study of pain. Oslo, (Invited speaker). Arendt-

Nielsen L. and Bjerring P. April 1989.

85. Inhibition of argon laser induced pricking pain by repeated applications of topical capsaicin. 13th

Annual Meeting of The Scandinavian Association for the Study of Pain. Arendt-Nielsen L. and

Bjerring P.

86. EEG actinity during hypnotically induced trance and fear - an investigation of regional changes.

Karl Gotliebsen, Lars Arendt-Nielsen, Peter Bjerring, Bobby Zachariae & Thomas Nielsen.

Topographic EEG Analysis and Brain Mapping, Saint-Vincent, Italien. 7.-10. September, 1989

87. Inhibition of argon laser induced pricking pain by repeated applications of topical capsaicin. Lars

Arendt-Nielsen & Peter Bjerring. Annual meeting of the Scandinavian Association for the Study of

Pain. Helsinki, June 1989.

88. Coagulation of condylomata acuminata with 578 nm irradiation by copper vapour laser.

Scandinavian Society for laser therapy. 2nd Meeting, Espoo, Finland. Peter Bjerring and Allan

Rohold. 15-17 October 1989.

89. A comparison of CO2 laser coagulation and copper vapour laser coagulation of condylomata

acuminata. Scandinavian Society for laser therapy. 2nd Meeting, Espoo, Finland. Peter Bjerring.

15-17. October 1989.

90. Laserbehandling i dermatologien. Wellcome Symposium for praktiserende læger, Odense, 9.

November, 1989.

91. Laserkoagulation af kondylomer med kobberdampslaser og CO 2 laser. Dansk Dermatologisk

Selskabs møde, Odense, 7. October 1989.

92. Antiinflammatorisk og analgetisk effekt af antihistaminer. Dansk Dermatologisk Selskabs møde,

Odense. 7. October 1989.

93. Applikationstider ved anvendelse af EMLA creme. Nordisk symposium: EMLA inom

dermatologi/venerologi (satellitsymposium til Nordisk Dermatolog Kongres). Peter Bjerring & Lars

Arendt-Nielsen. 11. June 1989.

94. Anaesthesidybde ved anvendelse af EMLA creme. Nordisk symposium: EMLA inom

dermatologi/venerologi (satellitsymposium til Nordisk Dermatolog Kongres). Peter Bjerring & Lars

Arendt-Nielsen. 11. June 1989.

95. Lokale variationer ved anvendelse af EMLA creme. Nordisk symposium: EMLA inom

dermatologi/venerologi (satellitsymposium til Nordisk Dermatolog Kongres). Peter Bjerring & Lars

Arendt-Nielsen. 11. June 1989.

96. Manglende effekt ved anvendelse af EMLA creme hos patienter med Ehlers-Danlos syndrom.

Nordisk symposium: EMLA inom dermatologi/venerologi (satellitsymposium til Nordisk Dermatolog

Kongres). Peter Bjerring & Lars Arendt-Nielsen. 11. June 1989.

CV Peter Bjerring, Professor, MD, Dr.Sci

97. Behandling af psoriasis med EMLA creme. Nordisk symposium: EMLA inom

dermatologi/venerologi (satellitsymposium til Nordisk Dermatolog Kongres). Poul Ølholm Larsen,

Peter Bjerring & Lars Arendt-Nielsen. 11. June 1989.

98. EMLA - modulation af hudrespons mod histamin og substance P. Nordisk symposium: EMLA inom

dermatologi/venerologi (satellitsymposium til Nordisk Dermatolog Kongres). Poul Ølholm Larsen,

Peter Bjerring & Lars Arendt-Nielsen. 11. June 1989.

99. Datasikkerhed i forbindelse med anvendelse og opbevaring af patientdata. 25. Nordiske

Dermatolog Kongres. København 11.-14. June 1989.

100. Kobberdamplaser behandling af hæmangiomer. P.H. Andersen, P. Bjerring & Marie Cramers. 25.

Nordiske Dermatolog Kongres. København 11.-14. June 1989.

101. Kvantitativ hæmning af kutan smerte og type i reaktion med EMLA creme. Peter Bjerring & Lars

Arendt-Nielsen. 25. Nordiske Dermatolog Kongres. København 11.-14. June 1989.

102. Behandling af postherpetiske smerter med capsaicin. Peter Bjerring, Lars Arendt-Nielsen & Ulla

Søderberg. 25. Nordiske Dermatolog Kongres. København 11.-14. June 1989.

103. Bifasisk respons efter EMLA creme applikation. Peter Bjerring & Lars Arendt-Nielsen. 25. Nordiske

Dermatolog Kongres. København 11.-14. June 1989.

104. Kutan analgesi vurderet med argonlaser inducerede kortikale respons. Jens Nielsen, Peter Bjerring

& Lars Arendt-Nielsen. 25. Nordiske Dermatolog Kongres. København 11.-14. June 1989.

105. Kvantitativ analgesi af normal hud med capsaicin. Peter Bjerring & Lars Arendt-Nielsen. 25.

Nordiske Dermatolog Kongres. København 11.-14. June 1989.

106. AS- and C-fiber cortical responses evoked by strong argon laser stimulation. Lars Arendt-Nielsen &

Peter Bjerring. XXXI International Congress of Physiological Sciences. Helsinki, Finland, 9-14. July

1989.

107. Copper vapour- and CO2-laser coagulation compared with CO2-laser evaporation for treatment of

condylomata acuminata. Laser 90, Manchester, February 1990.

108. A comparison of copper vapour laser and argon laser for the treatment of port wine stains. P.

Bjerring,P.H. Andersen, M. Cramers. Laser 90, Manchester, February 1990.

109. Soft laser behandling, - er der videnskabelig baggrund for virkningen. Dansk Medicoteknisk

Selskab, KAS Herlev, 28. February 1990.

110. Gotliebsen K, Arendt-Nielsen L, Bjerring P. Continuous regional changes in EEG power during

cold pressure pain. VIth World Congress on Pain, Adelaide Australien.1.-6. April

111. Andersen P H, Bjerring P. Non invasive determination of skin chromophores by computerized

analysis of skin reflectance spectra. 8th International Symposium on Bioengineering and the Skin,

Stresa, Italien, June 1990.

112. Bjerring P. Perspectivas futuras: Uso do laser de vapor decobre. Congresso Brasileiro de

Dermatologia, Sao Paulo, September 1990.

113. Bjerring P. Behandlingsresistente kondylomer. - Kobberdamplaser eller CO2-laser. Peter Bjerring

og Hans Hagdrup. 734. møde i Dansk Dermatologisk Selskab, October 1990.

114. Zachariae R, Bjerring P. Increase and decrease of delayed cutaneous reactions obtained by

hypnotic suggestions during sensitazation. Sixth International Congress of Psychophysiology.

Hospital Charité, Berlin. September 1992.

115. Andersen PH, Abrams K, Bjerring P, Maibach H. UVB induced erythema inhibited by topically

applied anti-inflammatory agents. J Invest Derm, April 1991.

CV Peter Bjerring, Professor, MD, Dr.Sci

116. Arendt-Nielsen L, Bjerring P, Øberg B. The onset phase of epidural and spinal bupivacaine

alangesia - a quantitative study. ESRA-VIth annual Meeting of the European Society of Regional

Anaesthesia. Paris, 7.-9. May 1990.

117 Arendt-Nielsen L, Bjerring P. The response to local anaesthetics (EMLA-cream) as a clinical test to

diagnose between hypermobility and Ehlers Danlos type III syndrome. ESRA-VIth annual Meeting

of the European Society of Regional Anaesthesia. Paris, 7.-9. May 1990.

118. Svensson P, Kaaber S, Bjerring P, Arendt-Nielsen L. Health factors and pain profiles in the burning

mouth syndrome. International Association for Dental Research, Scandinavian Division (N.O.F.),

Annual Meeting, Helsinki, Finland. August 1991.

119. Svensson P, Kaaber S, Arendt-Nielsen L, Bjering P. Oral sensory and pain thresholds to argon

laser stimulation in patients with a burbing mouth syndrome. International Association for Dental

Research, Scandinavian Division (N.O.F.), Annual Meeting, Helsinki, Finland, August 1991.

120. Svensson P, Arendt-Nielsen L, Kaaber S, Bjering P. Different laser types for experimental pain

stimulation on human oral mucosa. International Association for Dental Research, Scandinavian

Division (N.O.F.), Annual Meeting, Helsinki, Finland, August 1991.

121. Sindrup SH, Arendt-Nielsen L, Bjering P, Brøsen K, Angelo H, Eriksen B, Gram LF. Does

Quinidine block the analgesic effect of codeine?. Scandinavian Association for the Study of Pain,

Ebeltoft, May 1991.

122. Svensson P, Kaaber S, Arendt-Nielsen L, Bjering P. Oral sensory and pain thresholds to argon

laser stimulation in patients with a burbing mouth syndrome. Scandinavian Association for the

Study of Pain, Ebeltoft, May 1991.

123. Svensson P, Arendt-Nielsen L, Kaaber S, Bjering P. Different laser types for experimental pain

stimulation on human oral mucosa. Scandinavian Association for the Study of Pain, Ebeltoft, May

1991.

124. Brennum J, Arendt-Nielsen L, Secher NH, Jensen TS, Bjerring P. Sensory effects of high and low

lumbar epidural lidocaine. Scandinavian Association for the Study of Pain, Ebeltoft, May 1991.

125. Arendt-Nielsen L, Svensson P, Bjerring P, Brennum J. Reduced variability of pain evoked brain

potentials by new stimulation paradigms. Scandinavian Association for the Study of Pain, Ebeltoft,

May 1991.

126. Svensson P, Arendt-Nielsen l, Kaaber S, Bjerring P. Quantitative determination of pain thresholds

and pain-evoked pain potentials on topically anaesthetized oral mucosa. Europain Meeting,

Brussels, December, 1991.

127. Bjerring P, Lauridsen J, Arendt-Nielsen L. Video-optical monitoring of the time-course of wheal and

flare reactions. The 9th International Symposium on Bioengineering and the Skin. Sendai, Japan.

19.-20. October 1992.

128. Bjerring P, Cramers M. Laserbehandling af recidiverende condyloma acuminata. Dansk

Dermatologisk Selskabs møde 3. October 1992.

129. Bjerring P. Laserbehandling i dermatologien. Staff Meeting, Plastikkir. afd. Århus

Kommunehospital, 7. October 1992.

130. Øberg B, Arendt-Nielsen L, Bjerring P. The analgesic onset, efficacy and duration of intramuscular

alfentanil (Rapifen) evaluated quantitatively in human volunteers by argon laser induced pain. 10th

World Congress of Anaesthesiology, den Haag 1992.

131. Øberg B, Arendt-Nielsen L, Bjerring P. Analgesic efficacy of epidural morphine. 46th Congress of

The New York State Society of Anesthesiologists, New York 1992.

CV Peter Bjerring, Professor, MD, Dr.Sci

132. Bjerring P. Antiinflammatory activity of topical steroids. Dermatology Advances. München, October

1992.

133. Bjerring P. Potency ranking of topical steroids. Dermatology Advances. Monte Carlo, May 1993.

134. Øberg B, Arendt-Nielsen L, Bjerring P. Evaluation of intravenous regional anaesthesia using saline,

morphine, lidocaine or prilocaine. 11th Annual ESRA Congress, Dublin 1993.

135. Bjerring P. EMLA cream - basic properties and clinical applications. Vth Annual Meeting of the

National Society of Regional Anaesthesia, Barcelona, Spain, 22. May 1993.

136. Petersen-Felix S, Arendt-Nielsen L, Bjerring P, Bak P, Svensson P, Breivik H, Zbinden AM.

Ondansetron does not inhibit the analgesic potency of alfentanil. 22nd Congress of the

Scandinavian Society of Anaesthesiologists. Kuopio, Finland. 28.June 28 – 2. July 1993.

137. Bjerring P. Laser treatment of common warts. Nordic Dermatology Congress, Reykjavik, Iceland.

12. July 1993.

138. Bjerring P. Liposomes in dermatology. Nycomed-DAK Symposium, Copenhagen, 31. July 1993.

139. Bjerring P, Cramers M. Quality control and optimization of dermatological laser treatments using a

computerized data base. IIIth Congress of the European Academy of Dermatology and

Venereology, Copenhagen, September 1993

140. Bjerring P. Laser surgery of common warts. IIIth Congress of the European Academy of

Dermatology and Venereology, Copenhagen, September 1993.

141. Øberg B, Arendt-Nielsen L, Bjerring P. The analgesic onset, efficacy and duration of intramuscular

alfentanil (Rapifen) evaluated quantitatively in human volunteers by argon laser induced pain.

Proceedings from the 10th World Congress of Anaesthesiologists, Den Haag 1992 p 550.

142 Øberg B, Arendt-Nielsen L, Bjerring P. Analgesic efficacy of epidural morphine. Proceedings of the

46th Congress of The New York State Society of Anesthesiologists, New York 1992, p 432.

143. Arendt-Nielsen L, Bjerring P. Quantitative asessment of pain following treatment with ibuprofen

cream - clinical and experimental studies. March 1993.

144. Bjerring P. Topcial Steroids - Skin Physiological aspects. Scandinavian Conference on actiderm,

Visby, Sverige, August 1993.

145. Bjerring P. Dermatologisk Laserbehandling. Dansk Selskab for Aesthetisk Dermatologi.

Diakonissestiftelsen, 30. October 1993.

146. Bjerring P. Side effects of topical corticosteroids. Third Annual Meeting, The Americal Embassy,

København 22. November 1993.

147. Petersen-Felix S, Arendt-Nielsen L, Bjerring P, Bak P, Svensson P, Breivik H, Zbinden AM.

Ondansetron does not inhibit the analgesic potency of alfentanil. 22nd Congress of the

Scandinavian Society of Anaesthesiologists, Kuopio, Finland June/July 1993.

148. Bjerring P. EDB i dermatologisk speciallægepraksis. Jyske Dermatologers årsmøde, Åbenrå,

September 1993.

149. Bjerring P. Lasers and their use in dermatology and venereology. Schering Plough Meeting,

Marselisborg Hospital, 13. April, 1994.

150. Bjerring P. Lokale kortikosteroiders virkemåde og virkningsvarighed. Lægemøde, Vestlollands

Lægeforening, Nakskov, 19. March 1994.

151. Bjerring P. Laserbehandling. Dansk Tandlægeforenings Årskursus, København, 17.-19. March

1994.

CV Peter Bjerring, Professor, MD, Dr.Sci

152. Bjerring P. Experimental pain measurements. Astra Pain Meeting, Copenhagen, 20. April, 1994.

153. Bjerring P. Lasers and their use in dermatology and venereology. Laser- Tagung, University of

Zürich, Schweiz, April 1994.

154. Bjerring P. Medical use of lasers. Laser'94. Dansk Optisk Selskab og Dansk Fysisk Selskab,

Odense, April 1994.

155. Øster H, Zachariae R, Kragballe K, Bjerring P. Effects of psychological intervention on

physiological and psychlogical symptoms in psoriasis. Sixth International Psoriasis Symposium,

Chicago, June, 1994.

156. Christensen TM, Bjerring P. The effect of minoxidil on wound epithelialization and

neovascularization. Accepted for presentation: 4th Annual Meeting of the European Tissue Repair

Society, Oxford, England , 25. August 1994.

157. Bjerring P, Clement RM, Cramers M, Ternowitz T, Zachariae H. Flash lamp pumped dye laser

effects on normal skin reactions. Objectively measured by laser doppler skin blood flow an

reflectance spectrophotometry. Accepted for presentation at: Biomedical Optics Europe '94. Lille,

France, September 1994.

158. Lauersen K, Zachariae R, Bjerring P, Hansen TI. The role of pain-perception in the development of

sports injuries - an exploratory experimental investigation. The Scandinavinan Congress of Sports

Medicine. Copenhagen, November 1994.

159. Bjerring P. Skin physiology in relation to optical transcutaneous skin glucose measurements.

European Association of Diabetes, Dusseldorf, 27. September 1994.

160. Bjerring P. Dermatologisk laserterapi, - nye indikationer og behandlingsresultater ved anvendelse

af farvestoflaser. Jydsk Medicinsk selskab, Møde nr 490, September, 1994.

161. Bjerring P. Farvestoflaserbehandling. Dansk Dermatologisk Selskab 753. Møde, Århus, October

1994.

162. Heickendorff L, Bjerring P, Jøhnke H. Biochemical measurements of local side effects of typical

corticosteroids - effects on skin collagen production. European Academy of Dermatology and

Venereology, International Meeting "Skin Therapy Update '94", Crete, October 1994.

163 Bjerring P, Jøhnke H, Heickendorff L. Objective measurements of local side effects of typical

corticosteroids. European Academy of Dermatology and Venereology, International Meeting "Skin

Therapy Update '94", Crete, October 1994.

164. Bjerring P. Optical transcutaneous skin glucose measurements. 15th International Diabetes

Federation Congress, Kobe, Japan, 9. November 1994.

165. Svensson P, Arendt-Nielsen L, Bjerring P. Effect of oral pain induced by capsaicin on human

mastication. Proceedings from the 18th Annual Meeting. Scandinavina Association for the Study of

Pain (SASP), Lillehammar, Norge, 1994.

166. Bjerring P. Laserbehandling. Hvor er laserbehandling bedre end anden dermatologisk behandling.

Dansk Dermatologisk Selskabs Efteruddannelseskursus, Munkebjerg, January 1995.

167. Bjerring P. Laserbehandling i dermatologien. Jyske Dermatologer, Munkebjerg, February 1995.

168. Bjerring P. Dermatologisk laserterapi. Stig Herlitz Forelæsning, Örebro, Sverige, March 1995.

169. Bjerring P. Vorteile des CO2-Lasers gegenüber andere Laser- Neue Parameter - Fiberoptik. 3.

Fachtagung, Universität Zürich, March 1995.

170. Thastum M, Zachariae P, Schøler M. Bjerring P. Herlin T. Cold pressor pain: Comparing responses

of juvenile arthitis patients and their parents. 3rd European Conference on Pediatirc Rheumatic

Diseases, Gent, Belgium, April 1995.

CV Peter Bjerring, Professor, MD, Dr.Sci

171. Bjerring P. Dermatologisk laserbehandling. 1995 Årsmøde i Dansk Selskab for Patologisk Anatomi

og Cytologi. Randers, April 1995.

172. Bjerring P. Dermato-venerologisk laserbehandling. Staff-meeting, Århus Kommunehospital og

Marselisborg Hospital, May 1995.

173. Bjerring P, Molin L. Low Power CO2 laser treatment of genital condylomas. XXVII Nordiska

Dermatologkongressen, Åbo, Finland June 1995.

174. Kim S E, Heickendorff L, Bjerrring P, Kragballe K. Collagen metabolism in normal human skin after

application of calcipotriol: Stimulation of aminoterminal propeptide of the III procollagen (PIIINP)

but potentiation of the corticosteroid-induced inhibition of PIIINP. Meeting of The European Society

for Dermatological Research, 1995.

175. Bjerring P, Felsby S. Effect of two halogenated anaesthetics on blood flow in port wine stains and

normal skin - implications for laser treatment. The European Laser Association and The

dBiomedical Optics Society (BiOS Europe ´95, Barcelona, Spanien, September 1995.

176. Bjerring P. Hudens neurofysiology i relation till nålestick. Nordisk Kongres . Barn & Smerte,

Stockholm, September 1995.

177. Bjerring P. Lys i Hud. Dansk Optisk Selskabs Møde, Struer, October, 1995.

178. Bjerring P. CO2-Fiberoptik-Lasers in der Praxis. 4. Fachtagung, Universität Zürich, November

1995.

179. Bjerring P. Anvendelse af laserteknologi til ikke-invasiv diagnostik og til behandling af

dermatologiske lidelser. Professorattiltrædelsesforelæsning ved Aarhus Universitet, Århus,

November 1995.

180 Bjerring P. Cutaneous laser therapy. Podiatry Association Annual Seminar, Bromsgrove,

Birmingham, November 1995.

181 Bjerring P. Laser therapy. Klinikum der Christian-Albrechts Universität zu Kiel. February, 1996.

182. Zachariae H, Halkier-Sørensen L, Bjerring P, Heickendorff L. Treatment of ischemic digital ulcers

and prevention of gangrene with intravenous iloprost in systemic sclerosis. IVth Intermational

Workshop on Scleroderma Research, Christ's College, Cambridge, UK. 14.-16. July 1996.

183. Zachariae H, Bjerring P, Søndergaard K, Halkier-Sørensen L. Occupational scleroderma in males

from a Danish Dermatological Department. IVth Intermational Workshop on Scleroderma

Research. Christ's College, Cambridge, UK. 14.-16. July 1996.

184. VIIIth World Congress of Pain, Vancouver. August 1996.

185. Egekvist H, Bjerring P. Effect of EMLA on vein diameter. 11th World Congress of

Anaesthesiologists, Sidney 1996.

186. Egekvist H, Bjerring P, Arendt-Nielsen L. Anatomy and Physiology of the skin in relation to needle

insertion. Sensory-Motor Interaction Seminar, Aalborg Universitet. 1996.

187. Bjerring P. Skin neurophysiology. Novo Nordisk Symposium, Bagsværd, 1996.

188. Bjerring P. Ruby laser depilation. Fourth Scandinavian Laser Work Shop, Malmø, Sverige. 1996.

189. Bjerring P. Carbon dioxide laser treatment. 5. Fachtagung, Universität Zürich, Schweiz. 1996.

190. Bjerring P, Egekvist H, Zachariae H. Flash-lamp pumped dye laser for treatment of psoriasis.

Annual conference of the Biomedical Optics Society, Wien, Østrig, 1996.

CV Peter Bjerring, Professor, MD, Dr.Sci

191. Bjerring P. Lasere i dermatologien. Symposium om Biomedicinske anvendelser af optik. Risø

1996.

192. Bjerring P. Ruby laser depilation. Fifth Congress of the European Academy of Dermatology and

Venereology, Lissabon, Portugal. 1996.

193. Bjerring P. Laser therapy Symposium, Klinikum der Christian-Albrechts Universität zu Kiel, 1996.

194. Bjerring P. Ruby laser depilation. Annual Meeting of the German Academy of Cosmetic Surgery,

Köln, Tyskland. 1996.

195. Egekvist H, Bjerring P, Lybecker H, Zachariae H. Long pulse ruby laser depilation - preliminary

results. Fifth Congress of the Scandinavian Society for Laser Therapy, Aarhus, April 1997.

196. Thrane L, Andersen PE, Bjerring P. Biomedical optics at Risø National Laboratory: Optical

coherence tomography. Fifth Congress of the Scandinavian Society for Laser Therapy, Aarhus,

April 1997.

197. Zachariae H, Bjerring P, Søgaard H. The flashlamp-pumped dye laser and dermabrasion in

psoraisis. Fifth Congress of the Scandinavian Society for Laser Therapy, Aarhus, April 1997.

198. Hædersdal M, Egekvist H, Bjerring P. Side effects from hair removal with a long-pulse, free-

running ruby laser. Fifth Congress of the Scandinavian Society for Laser Therapy, Aarhus, April

1997.

199. Johansen LV, Bjerring P. Diode-Laser used in ENT patients. Fifth Congress of the Scandinavian

Society for Laser Therapy, Aarhus, April 1997.

200. Zachariae H, Bjering P, Lybecker H. Laser depilation using a free-running, long pulse ruby laser.

19th World Congress of Dermatology, Sydney, Australia, June 1997.

201. Bjerring P. Laser-assisted hair removal. Scandinavian Laser Workshop V - Advanced. University

Hospital and Plastic Surgery Center, Malmö, Sweden, August 1997

202. Andersen PE, Dam JS, Petersen PM, Bjerring P. Local Diffurse reflectance from three-layered skin

tissue structures. SPIE BiOS ´97 San Jose Convention Ctr. San Jose, California, February 1997.

203. Haker E, Egekvist H, Bjerring P. Effect of sensory stimulation (acupunkture) on sympathetic and

parasympathetic activity in healthy subjects. Barcelona, October 1997.

204. Zachariae R, Jorgensen M, Svendsen G, Bjerring P, Ehrnrooth E. Automoomic nervous sytstem

activity during relaxation and exposure to a mental stressor. Nineteenth Annual Scientific Sessions,

The Society of Behavioral Medicine, New Orleans. March 1998.

205. Egekvist H: Relations between pain and mechanical traumatisation of the human skin by needle

insertion. Aarhus-Berlin-Kiel Meeting, Aarhus, 11.-12. April 1997.

206. Egekvist H: Mekanisk traumatisering af huden ved nålestik: Relation tilsmerteopfattelsen. 761.

Ordinære møde i Dansk Dermatologisk selskab, Århus, 2.-3. May 1997.

207. Egekvist H: Systemisk Sclerodermi og ventrikel funktion og undersøgelser, electrogastrography.

Undervisning for læger, Dermato-venerologisk afdeling, Marselisborg Hospital, 13. May 1997.

208. Hædersdal M, Egekvist H, Bjerring P: Side effects from hair removal with a long-pulse, free-

running ruby laser. Scandinavian Laser Workshop V, Malmø, 23.-24. August 1997.

209. Egekvist H, Bjerring P: Cutaneous effects of retinyl cream evaluated with 20-MHz high-frequency

ultrasound - a placebo controlled human study. First World Congress of International Academy of

Cosmetic Dermatology (IACD), St. Juliens, Malta, 28.-31.January 1999.

CV Peter Bjerring, Professor, MD, Dr.Sci

210. Egekvist H, Zachariae H, Bjerring P, Arendt-Nielsen L: Pain evoked by controlled needle

insertions. Effects of cognitive coping strategies on the evoked pain. 9th World Congress on Pain,

Wien, Østrig 22.-27. August 1999.

211. Haker E, Egekvist H, Bjerring P: Effect of sensory stimulation (acupuncture) on sympathetic and

parasympathetic activity in healthy subjects. 9th World Congress on Pain, Wien, Østrig 22.-27.

August 1999.

212. American Academy for Cosmetic Surgery, Los Angeles, USA, 26.-29. January 1999.

213. 2nd Annual Congress of the European Society for Lasers and Surgery, Oxford, UK, 26.-28. March

1999.

214. 3rd International Laser Symposium, Tüttlingen, Tyskland, 24.-25. April 1998.

215. 19th Annual meeting of the American Society for Laser Medicine and Surgery, Orlando, USA, 13.-

18. April 1999.

216. XVIIIè Congres de la Societe Francaise des Lasers Medicaux, Nice 5. June 1999.

217. 5th International Aesculapium Symposium: Lasers in Medicine. Tüttlingen, Tyskland, 7.-8 May,

1999.

218. Journées Thématiques Laser. Hôpital l’Archet 2, Nice, Frankrig, 4. and 5. June 1999.

219. HHT Conference, Svendborg, Danmark, 19.-21. June, 1999.

220. BIOP Temamøde om Biomedicinsk Optik, Niels Bohr Auditoriet, Forskningscenter Risø. 22. June

1999.

221. International Workshop on Botulinumtoxin Type A for the treatment af hyperhidrosis. Würtzburg,

25. June 1999.

222. 6th International Congress of the International Society for Skin Imaging. London, UK, 4.– 6. July

1999.

223. Symposium on Biomedical Optics, BIOP, Danmarks Tekniske Universitet, Lyngby, Danmark, 21.

September 1999.

224. 8th Congress of the European Academy of Dermato Verereology Amsterdam, Holland, 29.

September – 3. October, 1999.

225. European Medical Laser Association: Laser Florence, Firenze, Italien, 29. – 31. October 1999.

226. Laser Workshop Zürich, 11. November 1999.

227. Dansk Dermatologisk Selskabs 100 års jubilæumsmøde, Panuminstituttet, København, 27.

November 1999.

228. Symposium om anvendelse af nye lasere, Kemisk Institut, Aarhus Universitet, 20. January 2000.

229. XIXè Congres de la Societe Francaise des Lasers Medicaux, Frankrig, 26.-27. januar 2000.

230. Infrared Thermography, Modern Developments, Dansk Selskab for Klinisk Fysiologi og

Nuklearmedicin, København, 22. February 2000.

231. Nordic Photodermatology Research Group Meeting, København, 25.-26. February 2000.

232. Lasersystemer og deres anvendelse til medicinsk diagnose og behandling, BIOP møde,

København, 15. March 2000.

CV Peter Bjerring, Professor, MD, Dr.Sci

233. International Congress of the European Society for Laser Aesthetic Surgery, (ESLAS), Tarragona,

Spanien, 24.-26. March 2000.

234. IXth Annual Meeting of the Deutsche Dermatologische Lasergesellschaft, Munich, 20. May, 2000.

235. Nlite Laser Congress, Athen, Grækenland, 20.-21. September 2000.

236. 5éme Journée de L’Association de Recherche en Esthéstique Dermatologique et Plastique, Paris,

Frankrig, 1. July 2000.

237. XXI Congress af the International Society for Dermatologic Surgery . Madrid, Spanien 21.

September 2000.

238. 9th Congress of the Eurppean Academy of Dermatology and Venereology, Geneve, 11.-15.

October 2000.

239. 5th Congress of the European Society af Laser Dermatology, 11.-15. October, Geneve, 2000.

240. Nlite Laser Congress, Dallas, USA, 28. October 2000.

241. 13th International Congress af Aesthetic Medicine, Monte Carlo, 1.-4. November 2000.

242. International Master Course on Ageing Skin. Paris, 12.-14. January 2001.

243. International Congress of the European Society for Laser Aesthetic Surgery.

244. American Society for Laser Medicine and Surgery, 21st Annual Meeting, New Orleans, 20.-22.

April 2001.

245. European Society for Laser Aesthetic Surgery Annual Meeting, Marseilles, 3.- 5. May 2001.

246. 41. Tagung der Deutsche Dermatologische Gesellschaft, Berlin, 5. May 2001.

247. 29th Nordic Congress of Dermatology and Venereology, Göteborg, 7.-10. June 2001.

248. Controversies and Conversations in Cutaneous Laser Surgery – An advanced symposium. Beaver

Creek, Colorado, 10.-12. August 2001.

249. Lasersystemer og deres anvendelse til medicinsk diagnose og behandling, BIOP møde,

København, 30. October 2001.

250. 10th Congress of the Eurppean Academy of Dermatology and Venereology, München, 10.-14.

October 2000.

251. Hamburger Kongress für Dermatologie und Kosmetik 2001. Hamburg 5.- 6. October 2001

252. 5th Congress of the European Society af Laser Dermatology, Geneve, 11.-15. October 2001.

253. Laser Trier 2001, Europäische Rechtsakademie, Trier, 2.-4. November 2001.

254. American College of Rheumatism Annual Congress, San Francisco, 12.-14. November 2001

255. Æresforelæsning ved Åbo Universitet: The Sonck lecture, 26. November 2001.

256. International Master Course on Ageing Skin, Paris, 8.-10. January 2003

257. Dansk Dermatologisk Selskabs Efteruddannelseskursus, Vejle, 22.-24. January 2003

258. Jyske Dermatologers Efteruddannelseskursus for Klinikpersonale, Vejle, 1. February 2003

259. Non- ablative Photorejuvenation Symposium, The Roman Baths, Launceston, Tasmania, Australia

21. March 2003

CV Peter Bjerring, Professor, MD, Dr.Sci

260. De små specialer, Lægeforeningen, Copenhagen, Denmark, 4. March 2003

261. Dansk Tandlægeforenings Årskursus 13.-15 March 2003

262. Photorejuvenation Symposium, Hamburg 29. March 2003

263. 23rd Annual Meeting of the American Society for Laser Medicine and Surgery, Anaheim, USA, 9.-

14 April

264. Nordisk Kursus i Plastikkirurgi, København, 28. April - 2. May 2003

265. Lasersymposium for Dermatologer, Privathospitalet Mølholm, Denmark, 7. June 2003.

266. Bio-Photonics, Hveen, Denmark, 18. June 2003.

267. Controversies and Conversations in Cutaneous Laser Surgery, Gleneden Beach, Oregon, USA,

8.–10. August 2003.

268. Galderma Symposium, Sophia-Antipolis, Frankrig 4.-7 September 2003.

269. 24e Congrés National de Médidine Esthétique et de Chirurgie Dermatologique, Paris, 12.- 14.

September 2003.

270. Joint International Laser Conference (ASLMS, ELA, British Laser Association) Edinburgh,

Scotland, 21.- 23 September 2003.

271. Lægedag Vejle Amt 26. September 2003.

272. Cosmetic Dermatology Jordan, Amman, Jordan, 1.-3. October 2003.

273. European Society for Laser Dermatology, Barcelona, 15. October 2003.

274. Biomedical Optics (BIOP) Symposium, Danmarks Tekniske Universitet, Lyngby, 28. October 2003,

275. DermoVest Møde, Bergen, Norge, 31.October 2003.

276. XXth International Intensive Hands-on Course on Laser in Medicine and Surgery, Cambrils,

Spanien, 14.-16. November 2003.

277. Niels Finsen Symposium, København, 27.-29. November 2003.

278. 6th International Congress of the European Society for Laser Aesthetic Surgery, Rome, 12.-14.

December 2003.

280. Controversies and Conversations in Cutaneous Laser Surgery, Mount Tremblant, Montreal,

Canada 10.–12. August 2004.

281. XXth International Intensive Hands-on Course on Laser in Medicine and Surgery, Cambrils,

Spanien, November 2004.

282. International Masters Course on Aging Skin (IMCAS), Paris. The future of laser assisted hair

removal. 6.-8. January 2006.

283. International Masters Course on Aging Skin (IMCAS), Paris. Understanding of pigmented lesions

suitable for laser treatment. 6.-8. January 2006.

284 Annual Meeting of the Dermatological Society of Thailand, Bangkok, 22.-25. February 2006.

285 Annual Meeting of the Dermatological Society of Thailand, Bangkok. Photorejuvenation and

Photodynamic Photorejuvenation with I2PL. 22.-25. February 2006.

CV Peter Bjerring, Professor, MD, Dr.Sci

286 Annual Meeting of the Dermatological Society of Thailand, Bangkok. New Technology with the

I2PL. 22.-25. February 2006.

287 Drosner Dermatology Symposium, Scuol, Schweiz. Der Arztberuf in Skandinavien. 17.-18. March

2006.

288 Anti-aging World Congress 2006, Paris. Photodynamic Therapy (PDT) for Rejuvenation: Is it

realistic?22.-23. March 2006.

289 South African Dermatology Congress, Durban. The new second Generation IPL – The European

Experience. 24.-27. May 2006.

290 South African Dermatology Congress, IPL, Durban, 24.–27. May 2006.

291 Cosmoderm VIII, Rotterdam. Non-ablative treatment. 8.-10. June 2006.

292 Cosmoderm VIII, Rotterdam. Photodynamic therapy for photorejuvenation, 8.-10. June 2006.

293 28. Jahrestagung der Vereinigung für Operative Dermatologie, Regensburg, Medical applications

of IPL. 23.-25. June 2006.

294 28. Jahrestagung der Vereinigung für Operative Dermatologie, Regensburg, IPL hands on

workshop, 23.-25. June 2006.

295 Controversies and Conversations in Dermatology, Carlsbad, Californien, 11.-13. August 2006.

296 Societe Francaise de Dermatologie Chirurgicale et Esthetique (SFDCE), Paris. Photodynamic

photorejuvenation with IPL. 29.-30. September 2006.

297 Societe Francaise de Dermatologie Chirurgicale et Esthetique (SFDCE), Paris. Medical

applications of IPL – workshop. 29.-30. September 2006.

298 European Academy for Dermatology and Venereology (EADV) Rhodos, 4.-8. October 2006.

299 European Academy for Dermatology and Venereology (EADV) Rhodos, Photodynamic therapy

with 5-ALA for skin rejuvenation 4.-8. October 2006.

300 European Academy for Dermatology and Venereology (EADV) Rhodos, Update in ALA PDT in

Acne, Hair & PR 4.-8. October 2006.

301 European Academy for Dermatology and Venereology (EADV) Rhodos. IPL and vit A cream

combination therapy in photorejuvenation - objective measurements using high frequency

ultrasound. 4.-8. October 2006.

302 8. Internationales Darmstädter Live-Symposium für Dermatochirurgie und Âsthetik. Frankfurt.

Photodynamische Hautverjüngerung, Effekte auf Akne und Hautoberfläche. 2.-5. November 2006.

303 8. Internationales Darmstädter Live-Symposium für Dermatochirurgie und Âsthetik. Frankfurt.

Photodynamische Hautverjüngerung, Stæudien über Hautfluoreszenz und Sicherheitsaspekte. 2.-

5. November 2006.

304 IPL Workshop, Department of Dermatology, University Hospital, Regensburg, Tyskland. Medical

applications of IPL. Hands-on workshop on IPL treatments in dermatology. 30. November – 1.

December 2006.

305 13. XXIII Curso Internacional Práctico Intensivo Láser en Medicina y Cirugía, Cambrils, . A novel

system for objective analysis of desquamation Spain, 10.-11.-12. November 2006.

306 13. XXIII Curso Internacional Práctico Intensivo Láser en Medicina y Cirugía, Cambrils, Spain.

Photodynamic skin rejuvenation with low-concentration 5-ALA and IPL. 10.-12. November 2006.

CV Peter Bjerring, Professor, MD, Dr.Sci

307 14. 5th World Congress of the International Academy of Cosmetic Dermatology, Melbourne,

Australia. The use of photodynamic therapy: is there a place for this treatment in dermocosmetics.

10.-13. December 2006.

308 14. 5th World Congress of the International Academy of Cosmetic Dermatology, Melbourne,

Australia. Lasers versus IPL: Does it really matter? 10.-13. December 2006.

309 International Masters Course on Ageing Skin, Paris: Photodynamic photorejuvenation with ALA

and IPL . 11.-14. January 2007.

310 International Masters Course on Ageing Skin, Paris: Photodynamic Photorejuvenation Course.

11.-14. January 2007.

311 International Masters Course on Ageing Skin, Paris, 11.-14. January 2007.

312 Teoretisk speciallægekursus (A-kursus) for yngre dermatologer, Århus Sygehus, Laser - Skin

tissue interactions. 5. March 2007.

312 International Masters Course on Ageing Skin, Paris, 11.-14. January 2007.

313 X International Meeting of Treatment in Dermatology. Old lasers – New applications. Porto,

Portugal 16. and 17 March 2007.

314 X International Meeting of Treatment in Dermatology. New Applications of Lasers and IPL in

Dermatology, Porto, Portugal 16. and 17 March 2007.

315 Anti Ageing World Congress, Monaco. Polychromatic light and rejuvenation of the body. 22.–25.

March 2007.

316 Anti Ageing World Congress, Monaco. Dynamic Photo therapy with I2PL for rejuvenation. 22.–25.

March 2007.

317 American Society for Lasers in Surgery and Medicine. Grapewine, Texas. The relevance of the

structure of time-resolved spectral output to light-tissue interaction using intense pulsed light (IPL).

12.– 15. April 2007.

318 European Academy of Dermatology and Venerology (EADV), Wien. Collagen remodelling with

I2PL. 15.-20. May 2007.

319 European Academy of Dermatology and Venerology (EADV), Wien, Photodynamic

Photorejuvenation – An Update. 15.-20. May 2007.

320 European Academy of Dermatology and Venerology (EADV), Wien. Indications for IPL systems.

15.-20. May 2007.

321 European Society for Laser Aesthetic Surgery, Athens. Photodynamic Photorejuvenation with low-

concentration 5-ALA and IPL. 24.-27. May 2007.

322 European Society for Laser Aesthetic Surgery, Athens. Fractionated CO2 laser resurfacing. 24.-27.

May 2007.

323 Japanese Aesthetic Dermatology 25th Annual Meeting, Yokohama. Liposome encapsulated 5- ALA

for photo rejuvenation. 16.-21. August 2007.

324 Galderma Symposium for danske dermatologer, Broholm Gods. Lys, Laser og PDT mod acne og

rosacea – i kombination med medikamentelle behandlinger. 7. September 2007.

325 Laserkursus, Fysisk Institut, Århus Universitet. Anvendt laserfysik. 10. September 2007.

326 Workshop for Doctors, Tivoli, København. Fractionated CO2 laser rejuvenation with the Juvia CO2

laser. 22. September 2007.

CV Peter Bjerring, Professor, MD, Dr.Sci

327 21st World Congress of Dermatology, Buenos Aires, Argentina.The relevance of the structure of

time-resolved spectral output to light tissue interaction using intense pulsed light (IPL). 30.

September-5. October 2007.

328 21st World Congress of Dermatology, Buenos Aires, Argentina. PDT in Europe. 30.September-5.

October 2007.

329 21st World Congress of Dermatology, Buenos Aires, Argentina. Photo- and chrono-aging – non

ablative procedures. 30. September-5. October 2007.

330 European Congress in Aesthetic Dermatology and Surgery. Paris, Current state of photo dynamic

therapy (PDT) in Cosmetic Dermatology: Alone or combined? Comparison with other non-ablative

treatments.12.-14. October 2007.

331 Nordisk Laserkusus for Dermatologer, Stavanger,. Aparatlære - lasers og IPL. 19.-20. October

2007.

332 Nordisk Laserkusus for Dermatologer, Stavanger. Vaskulære lidelser: perkutan interstitiell

diodelaserbehandling. 19. and 20. October 2007.

333 Nordisk Laserkusus for Dermatologer, Stavanger, Laser- og IPL-PDT behandlinger. 19. and 20.

October 2007.

334 Nordisk Laserkusus for Dermatologer, Stavanger. Ar efter kirurgi og acne: IPL og

kombinationsbehandlinger. 19. and 20. October 2007

335 Nordisk Laserkusus for Dermatologer, Stavanger. Photodynamisk photorejuvenation,

fraksjonelt ablative behandlinger. Fraksjonert CO-2 laser rejuvenation. 19. and 20. October 2007

336 International Society for Dermatologic Surgery, Venedig, .Fractionated CO2 laser resurfacing with

12 W average power. 25. - 27. October 2007.

337 International Society for Dermatologic Surgery, Venedig. Photodynamic Photorejuvenation with

0.5% liposomal encapsulated 5-ALA. 25.- 27. October 2007.

338 International Society for Dermatologic Surgery, Venedig. Scar Management with IPL Devices and

Lasers. 25.- 27. October 2007.

339 XXIII Curso Internacional Práctico Intensivo Láser en Medicina y Cirugía, Cambrils, Spain,

Photodynamic skin rejuvenation with low-concentration 5-ALA and IPL. 10.-12. November 2007.

340 A-kursus for læger under uddannelse til speciallæge i dermato-venerologi, Bispebjerg Hospital,.

Laserapparatur og kliniske laserbehandlinger. 14.-16. November 2007.

341 6th Annual Laser Conference in Trier (Laser-Trier), Tyskland. Acnetherapie mit IPL. 16.-18.

November 2007.

342 Ellipse Users’ Workshop, Dubai, United Emirates. Hair removal and skin rejuvenation. 8.-10.

December 2007.

343 Ellipse Users’ Workshop, Dubai, United Emirates. Liposome encapsulated photosensitizer for

wrinkle reduction treatment and improvements in skin texture. 8.-10. December 2007.

344 International Masters Course on Aging Skin (IMCAS), Paris. Live Demo Ellipse Juvia. 9.-12.

January 2008.

345 International Masters Course on Aging Skin (IMCAS), Paris. New Fractional CO2 laser vs. other

CO2 lasers. 9.-12. January 2008.

346 International Masters Course on Aging Skin (IMCAS), Paris. Spectral measurements of different

IPL. 9.-12. January 2008.

CV Peter Bjerring, Professor, MD, Dr.Sci

347 American Society for Lasers in Surgery Medicine (ASLMS), Florida. Clinical and in-vitro

investigation of Low-Fluence Photoepilation with an IPL System (Tom Nuijs, Lenieke Evers, Guido

Roosen, Gill Westgate, Peter Bjerring, Patricia van Kemenade and Michiel Roersma). 2.-6. April

2008.

348 American Society for Lasers in Surgery Medicine (ASLMS), Florida. Effect of Varying IPL Pulse

Structures on Human Skin Evaluated Using an Etythema Meter (Peter Bjerring, Godfrey Town,

Caerwyn Ash). 2.-6. April 2008.

349 American Society for Lasers in Surgery Medicine (ASLMS). Florida. Topical Rose Bengal for

Photodynamic Treatment of Psoriasis (Eric Wachter, Peter Bjerring). 2.-6. April 2008.

350 Anti Ageing World Congress, AAWC, Paris, Frankrig. I2PL and photo-dynamic therapy with .5%

ALA photo-spray. 10.-12. April 2008.

351 SIDCO (Italian Society for Dermatologic Surgery) National Congress, Perugia, Italien. The role of

lasers and IPL sources in skin rejuvenation (18. April). 16.-19. April 2008.

352 Mølholm Symposium for Foreningen af Yngre Dermatologer, Privathospitalet Mølholm, Vejle: IPL i

dermatologi. 3. May 2008.

353 ESLAS, Firenze, Italien. Topical tretinoin, AHA, and 5-ALA as adjuvant therapies in second

generation IPL photorejuvenation. 9.-10. May 2008.

354 ESLAS, Firenze, Italien. Fractional CO2 laser rejuvenation with low spot density and high fluency.

9.-10. May 2008.

355 Research Symposium Celebrating 25 Years of Pain Research at Aalborg University. Center for

Sensory-Motor Interactions (SMI), Aalborg. Lasers: How they ended up in experimental pain

research - and future. Perspectives. 6. June 2008.

356 Galderma Meeting on Botulinum toxin A, Nice, France. Botulinum Toxin treatment of the Forehead.

4.-6. September 2008.

357 17th European Academy of Dermatology and Venereology (EADV) Congress, Paris, France.

Fractional CO2 laser for skin rejuvenation (ESCAD symposium, Wednesday 17. September at

1230). 17.-21. September 2008.

358 17th European Academy of Dermatology and Venereology (EADV) Congress, Paris, France.

Adjunctive treatments and optical skin rejuvenation. 17.-21. September 2008.

359 17th European Academy of Dermatology and Venereology (EADV) Congress, Paris,

France.Nonablative rejuvenation (course C19 on Cosmetic dermatology and laser). 17.-21.

September 2008.

360 International Society for Dermatologic Surgery, Las Vegas, USA. Low Density, High Fluence

Fractional CO2 Laser Rejuvenation. 2.-5. October 2008.

361 International Society for Dermatologic Surgery, Las Vegas, USA. New developments in

professional and home IPL devices. 2.-5. October 2008.

362 PDT symposium, Erasmus University, Rotterdam, The Netherlands. PDT for skin rejuvenation. 26.

September 2008.

363 Galderma Symposium, Stockholm, Sweden. Laser- og IPL-behandling af acne. 10. October 2008.

364 XXV International Intensive Hands-on Course on Laser in Medicine and Surgery. Fundacion Antoni

de Gimbernat, Cambrils, Spanien. Which photo-treatment for which skin condition? My personal

recommendation. 14.-16. November 2008.

365 XXV International Intensive Hands-on Course on Laser in Medicine and Surgery. Fundacion Antoni

de Gimbernat, Cambrils, Spanien. Future direction in dermocosmetics. 14.-16. November 2008.

CV Peter Bjerring, Professor, MD, Dr.Sci

366 9th Darmstadt Live Symposium, Frankfurt, Germany, 3. - 7. December 2008.

367 International Masters Course on Aging Skin (IMCAS), Paris. Photodynamic photorejuvenation of

sun damaged skin with reduced side effects. 8.-11. January 2009.

368 International Masters Course on Aging Skin (IMCAS), Paris. How to evaluate an aesthetic home

device. 8.-11. January 2009.

369 Anti-aging Medicine World Congress, Monaco. Chairman. Use of CO2 laser: old and newest

technologies. 19.-21. March 2009.

370 Anti-aging Medicine World Congress, Monaco, I2PL and photodynamic therapy. 19.-21. March

2009.

371 Anti-aging Medicine World Congress, Monaco.I2PL versus PDL. 19.-21. March 2009.

372 Galderma Nordic’s Advanced Botulinum Toxin Course, Privathospitalet Mølholm, Vejle. Course

director. Botulinum toxin A - baggrund og virkningsmekanismer. August 2009.

373 Galderma Nordic’s Advanced Botulinum Toxin Course, Privathospitalet Mølholm, Vejle. Botulinum

toxin A - kliniske studier og evidens. August 2009.

374 Galderma Nordic Utbildningsdag: Rejuvenation of the face, Stockholm. Botulinum toxin A -

bakgrund, verkningsmekanismer, kliniska studier. 5. September 2009.

375 Galderma Nordic Utbildningsdag: Rejuvenation of the face, Stockholm. IPL fotorejuvenation. 5.

September 2009.

376 Guest lecturer, Institute for Physics, Århus University. Applied Laser Physics. 7. September 2009.

377 5 Continent Laser Meeting, Nice, France. Innovations in PDT and cancer detection. 10.-12.

September 2009.

378 5 Continent Laser Meeting, Nice, France. Positioning of home use devices in the field of optical

depilation. 10.-12. September 2009.

379 18th European Academy of Dermatology and Venereology (EADV) Congress, Berlin. Chairman

ESLD Symposium. Fluorescence aided diagnosis of early and latent pre-cancers and skin

carcinomas. 7.-11. October 2009.

380 Nordic Laser Course for Dermatologists, Stavanger, Norway. Course Director. Apparatlære del I.

10.-11. October 2009.

381 Nordic Laser Course for Dermatologists, Stavanger, Norway.Apparatlære del 2. 10.-11. October

2009.

382 Nordic Laser Course for Dermatologists, Stavanger, Norway. Perkutan interstitiell diodelaser

behandling. 10.-11. October 2009.

383 Nordic Laser Course for Dermatologists, Stavanger, Norway. Laser- og IPL-PDT behandlinger.

10.-11. October 2009.

384 Nordic Laser Course for Dermatologists, Stavanger, Norway. Arr etter kirurgi og acne: IPL og

kombinasjonsbehandlinger. 10.-11. October 2009.

385 Nordic Laser Course for Dermatologists, Stavanger, Norway. Rhytider og ujevn hudstruktur:

photodynamisk photorejuvenation, fraksjonelt ablative behandlinger, fraksjonert CO2 laser

rejuvenation. 10.-11. October 2009.

385 Nordic Laser Course for Dermatologists, Stavanger, Norway. Organisering av

laseravsnitt/lasersenter/laserklinikk: visitasjon, annonsering, apparater. 10.-11. October 2009.

CV Peter Bjerring, Professor, MD, Dr.Sci

386 International Masters Course on Aging Skin (IMCAS), Paris. Fibroblasts & Light: Updated

Fundamental Interactions. 9.-11. January 2010.

387 International Masters Course on Aging Skin (IMCAS), LED Limits. Paris 9.-11. January 2010.

388 International Masters Course on Aging Skin (IMCAS), Paris. Importance of laser parameters in

ablative and non-ablative fractional CO2 laser resurfacing. 9.-11. January 2010.

389 Galderma Nordic Azzalure Workshop for Dermatologists, Paris. Chairman and lecturer. 11.

January 2010.

390 Galderma Nordic Symposium for Danish Dermatologists, Munkebjerg, Denmark. Botulinum Toxin

A – from anatomy to aesthetic indications. 20. January 2010.

391 The European Society for Photodynamic Therapy. Monte Carlo, Monaco. Light sources for

aesthetic PDT. 12.-13. March 2010.

392 American Society for Lasers in Surgery and Medicine, Phoenix, Arizona. A highly effective new

microspot based IR-laser for home use skin rejuvenation – a randomized double-blinded

prospective ultrasonographic study. 16.-18. April 2010.

393 Galderma Nordic Symposium, Oslo, Norge: Botulinum Toxin A – from anatomy to aesthetic

indications. 29. May 2010.

394 Folkeuniversitetet Århus. Medicinske anvendelser af lys. 7. October 2010.

395 European Academy of Dermatovenereology Annual Meeting, Gøteborg: Photofacial and other

procedures to clear signs of skin ageing. 6.-10. October 2010.

396 European Academy of Dermatovenereology Annual Meeting, Gøteborg. What’s new above the

horizon. 6.-10. October 2010.

397 European Academy of Dermatovenereology Annual Meeting, Gøteborg. Early side effects in

cosmetic dermatological treatments. 6.-10. October 2010.

398 Darmstädter Live Symposium, Frankfurt, Germany: Home treatment Devices for PDT skin

Rejuvenation. 2.-5. December 2010.

399 Galderma Nordic Filler Symposium, Copenhagen. Hyaluronic acid fillers. 26. March 2011.

400 Ergoline symposium, Frankfurt, Germany: The New Tanning Parlor Treatment Collagen Solarium.

3. April 2011.

401 Ergoline symposium, Frankfurt, Germany: Adjunctive Treatment to Collagen Solarium Treatment.

3. April 2011.

402 Symposium on combined facial treatments, Malmoe: Combination treatment with botulinum toxin

and hyaluronic acid fillers. 15. May 2011.

403 22nd World Congress of Dermatology, Seoul, Korea: Permanent hair reduction obtained after

Intense Pulsed Light (IPL) treatments. Data based on 5-10 years follow-up. 24.-29. May 2011.

404 Ellipse IPL Symposium, Seoul, Korea: Ellipse vascular treatments. 27. May 2011.

405 Advanced Azzalure (Botulinum Toxin) Course, Copenhagen: Clinical evidence and international

consensus on botulinum toxin treatment of the lower face and neck. 18. June 2011.

406 5 Continents Congress, Cannes, chairman and speaker: Applications of Home-Use Devices under

Medical Supervision, P. Bjerring. 31. August-3. September 2011.

CV Peter Bjerring, Professor, MD, Dr.Sci

407 5 Continents Congress, Cannes, chairman and speaker: PDT and fractional laser drug delivery.

31. August-3.September 2011.

407 5 Continents Congress, Cannes, chairman and speaker: Introducing the all new Excel V Vascular

laser (Cutera Symposium). 31. August-3. September 2011.

408 5 Continents Congress, Cannes, chairman and speaker: PDT and Acne. 31. August-3. September

2011.

409 7th EMAA Paris: If you would have one laser to buy and according to your experience, what would

be your choice? 30. September and 1. October 2011.

410 7th EMAA Paris: Neck rejuvenation with fractional laser. 30. September and 1. October 2011.

411 20th Congress of the European Academy of Dermatology (EADV), chairman and speaker:

Advanced Cosmetic Surgery. 20.-24. October 2011.

412 20th Congress of the European Academy of Dermatology (EADV) 2011: Complications in skin

resurfacing, 20.-24. October 2011.

413 Nordic Laser Course for Dermatologists, Stavanger, Norway. Course Director. Samspillet mellom

lys og hudens strukturer. 11.-12. November 2011.

414 Nordic Laser Course for Dermatologists, Stavanger, Norway. Course Director. Lasere: prinsipper,

typer og klinisk anvendelse. 11.-12. November 2011.

414 Nordic Laser Course for Dermatologists, Stavanger, Norway. Course Director. Intense Pulsed Light

behandlinger: prinsipper, indikasjoner og kliniske eksempler. 11.-12. November 2011.

415 Nordic Laser Course for Dermatologists, Stavanger, Norway. Course Director. Rhytider og ujevn

hudstrukturer. 11.-12. November 2011.

416 Nordic Laser Course for Dermatologists, Stavanger, Norway. Course Director. Nye trends i estetisk

og korrektiv dermatologi. 11.-12. November 2011.

417 Galderma Advanced Azzalure Congress, Malmoe, Sweden. Clinical evidence and international

consensus on botulinum toxin treatment of the lower face and neck. 22. March 2012.

418 Anti-Aging Medicine World Congress, Monte Carlo, Monaco. 29. March-4. April 2012.

1: PDT Assisted Rejuvenation – How far can we go?

2: Photodynamic Photorejuvenation with IPL

419 Danish Technical University, Fotonik. Introduction to Biophotonics. 19. April 2012.

420 Laser Europe Congress, London, UK, 9.- 13. May 2012

1: Advanced PDT for skin rejuvenation with an introduction to home devices

2: Efficacy and Evaluation of CO2 laser Fractional Resurfacing

421 European Academy of Dermato-Venereology Congress, Verona, Italy. Present and Future Trends

of Vascular and Pigment Lasers. 5.-10. June 2012.

422 Cosmetic Light and Cream Congress, Las Vegas, USA, 25.-28. June 2012

1: Red Light enhancing active creams

2: UV-Light enhancing active creams

423 Galderma Azzalure Master Class Course, Malmoe, Sweden, Anatomy, Neurophysiology and

Pharmacology of Botulinum Toxin. 24. August 2012.

424 Photodynamic Therapy Meeting, Mølholm Hospital, Vejle, Denmark, 18. September 2012

1: Metvix – Mode of action

2: Which Skin Lesions can be Treated with PD

3: PDT Update – Latest News

CV Peter Bjerring, Professor, MD, Dr.Sci

425 Galderma Azzalure Master Class Course, Copenhagen, Denmark. Botulinum toxin type A

evidence and clinical studies. 23. September 2012.

426 European Academy of Dermato-Venereology, Prague, Czech Republic. PDT assisted rejuvenation:

How far can we go? 27. September 2012.

427 European Society for Lasers in Dermatology, Prague, Czech Republic: New ways of delivering

laser light. 29. September 2012.

428 Galderma Nordic Trainers’ Meeting, Stockholm. Advanced Azzalure: Neuromuscular junctions. 6.

October 2012.

429 Light and Cosmetic Creams Conference, Nashville, USA 19.-22. October 2012

1: Cosmeceuticals: Scientifically proven efficacious creams

2: Cosmeceuticals as adjuvant treatment to light treatments

430 First World Meeting on Lasers, Catania, Italy, 25.-27. October 2012

1: Present indications for IPL treatments

2: Treatment of epidermal pigmentation with IPL

3: Home treatment with optical devices – are they effective?

431 Board Certification Course for Danish Dermatologists, Odense, Denmark, 16. November

1: Clinical cases and multiple choice test

2: Rejuvenation procedures

432 Four Seasons Meeting, Molholm Hospital, Vejle, Denmark, Molholm Hospital, Organization and

Research Activities. 13. December 2012.

433 International Masters Course on Aging Skin (IMCAS), Paris, 31. January - 2. February 2013

Chairman

1: Home-treatments with fractional lasers

2: Intense pulsed light photoepilation is permanent: 5-9 years follow-up

434 Anti-aging Medicine World Congress, Monte Carlo, Monaco, 4.-7. April 2013

1: PDT as The art and science of photodynamic skin rejuvenation

2: PDT as skin cancer prevention: A new challenge for skin health?

435 European Academy of Dermato-Venereology, Crachow, Poland. Home-based light devices: How

do they fit in modern dermatologic scenario. 23.-26. May 2013.

436 The Annual EURO-PDT Congress, Madrid, Spain: PDT and low-cost fractional non-ablative laser.

31. May-1. June 2013.

437 European Academy of Dermato-Venereology (EADV) Fostering Course on Aesthetic Dermatology

and Lasers, Bukarest, Rumania, 8.-9. June 2013.

1: IPL in Dermatology

2: Fractional ablation and Resurfacing

3: Hands-on Training on CO2 lasers

438 5-Continent Congress, Cannes, France, 18.-22. September 2013.

1: PDT as skin cancer prevention

2: Home treatments with fractional lasers

439 European Academy of Dermato-Venereology (EADV), Istanbul, Turkey, 2.-6. October 2013

Chairman

1: PDT effects on aging skin – the real story

2: Advanced laser treatment performed as home treatment

440 Nordic Laser Course for Dermatologists, Stavanger, Norway, 25. November 2013. Course Director.

1: Samspillet mellom lys og hudens strukturer

2: Lasere: prinsipper, typer og klinisk anvendelse

CV Peter Bjerring, Professor, MD, Dr.Sci

3: Intense Pulsed Light behandlinger: prinsipper, indikasjoner og kliniske eksempler

440 Nordic Laser Course for Dermatologists, Stavanger, Norway, 26. November 2013. Course Director.

New trends in corrective dermatology

441 Galderma Brimonidine Meeting, Stockholm, 14. January 2014

1: Brimonidine – A bright future

2: Brimonidine - From a dermatologist’s perspective

442 Galderma Advisory Board on PDT Meeting, Paris, 29. January 2014,

1: Fluorescence diagnosis of latent and early actinic keratosis and non-melanoma skin cancers

2: Definition of Photodamage

3: Daylight PDT

443 Anti-aging Medicine World Congress, Monte Carlo, Monaco 3.-5. April 2014

1: PDT performed as home treatment

2: Types of lasers, light sources and their indications

444 European Academy of Dermato-Venereology, Amsterdam 8-12 October 2014

1: New ideas regarding how to use our facilities that we already have.

2: Skin rejuvenation and cosmetics - Spotlights in Dermatology

445 14th Annual Congress of the European Society for Photodynamic Therapy (Euro PDT). Home-based

laser device treatment to warm the skin as an alternative to curettage for pre-treatment before PDT.

4.-5. April 2014.

446 Yngre Dermatologer uddannelsesweekend, Korsør: Intense pulsed Light and Cosmeceuticals.

September 2014.

447 Darmstädter Live Symposium, Frankfurt, Germany: Indoor daylight photodynamic therapy for actinic

keratoses and skin rejuvenation. 4.-7. December 2014.

448 Nordic Course in Plastic Surgery, Bergen, Norway, 25. November 2014

1: Lasers

2: Intense Pulsed Light

449 Speciallægekursus i dermatologi, Pædiatrisk dermatologi og laser, Bispebjerg Hospital, Copenhagen,

26. November 2014

1: Rejuvenation procedures

2. Clinical cases

450 Cosmexchange Congress, Trieste. Anti-aging PDT home treatment: does it work? 12.-14. February

2015.

451 See The Light, Daylight PDT, Madrid, Spain, 3.-5. March 2015.

1: Actinic Keratoses is not an individual lesion disease – The concept of Field Actinic Damage.

2: Different ways of delivering daylight-PDT in Europe: Carrying out treatment in thje office: pros et

cons.

452 Anti-aging Medicine World Congress, Monte Carlo, Monaco 26.-28. March 2015

1: Advanced combination strategies in aesthetic and oncologic PDT

2: Is paradoxical hair growth caused by low level radiant exposure by home-use laser and intense

pulsed light devices

453 Galderma Nordics PDT-symposium, Stockholm, Sweden. Tips, Tricks and Experiences from a Large

PDT Practice. 17.-18. April 2015.

454 European Academy of Dermato-Venereology Fostering Course, Trieste, 14.-16. May 2015

1: Buying and Maintaining Lasers, Light- and RF Systems

2: Who and How should use Lsers, Light and RF systems

CV Peter Bjerring, Professor, MD, Dr.Sci

3: Active Chromophores for photo-activation: Fundamentals of PDT

4: Pre-and Post Treatment Care, - the Remodelling Phase

455 World Congress of Dermatology, Vancouver, Canada, 8.-15. June 2015

1: Light sources and treatment protocols in pigmented lesions

2: Daylight PDT for Skin Rejuvenation

456 5-Continent Congress, Cannes, France, 03.-06. September 2015

1: IPL, Principles and Indications

2: Treatment of Autoimmune diseases

3: Is paradoxical hair growth caused by low-level radiant exposure from home-use laser and intense

pulsed light devices?

4: A new IPL System with Ultrashort (0.5ms) pulses

5: New Modifications of Daylight-PDT for Skin Rejuvenation and for Actinic

Keratoses

457 Institute of Physics and Astronomy, Aarhus University. Dermatological applications of lasers. 1.

October 2015.

458 European Academy of Dermato-Venereology, Copenhagen, Denmark, 7. -11. October 2015

1: New concepts in IPL treatments

2: Ablative versus non-ablative fractional lasers in corrective and aesthetic dermatology

459 Annual Dermatology Meeting, Bucharest, Romania. A multifaceted approach to the management of

rosacea. 21. October 2015.

460 Galderma Nordics dermatologisymposium, Kolding, Denmark. Guidelines for Daylight PDT Treatment.

30.-31. October 2015.

461 Nordic Course in Plastic Surgery, Bergen, Norway, 23.-27. November 2015.

1: Lasers

2: Intense Pulsed Light

462 Galderma Nordics dermatologisymposium, Stockholm, Sweden. Challenging Facial Dermatoses. 27.

November 2015.

463 Københavnske Dermatologers Klub, Copenhagen. Kosmetisk dermatologi og dagslys PDT-

behandling. 6. January 2016.

464 International Masters’ Course on Ageing Skin. Paris, France, 28.-31. January 2016.

1: Nd:YAG Laser Treatment Of Periocular Veins

2: Biofilm Formati on In Injected Filler Materials

3: Optimized Settings For Nd:YAG Laser Treatments Of Leg Telangiectasias

465 Anti-aging Medicine World Congress, Monte Carlo, Monaco, 31. March-2. April 2016.

1: Periocular dark circles: Nd:YAG laser of lower eyelid veins.

2: Latest updates in Lasers and EBD Your lecture: Advances in Daylight-Photodynamic Therapy for

Chronic Sun Damages

466 Beauty Skills Lab Course, Molholm Hospital, Denmark, 16. April 2016.

1: Botulinumtoksin: Kemi, virkning, bivirkning

2: Lovgivning indenfor det kosmetiske område

467 European Academy of Dermato-Venereology Fostering Course, Trieste, 5.-7. May 2016.

1: Buying and Maintaining Lasers, Light- and RF Systems

2: Who and How should use Lsers, Light and RF systems

3: Active Chromophores for photo-activation: Fundamentals of PDT

4: Pre-and Post Treatment Care, - the Remodelling Phase

468 11th International Beauty Through Science Meeting, Stockholm, Sweden, 26.-28.May 2016.

1: New concepts in IPL treatments

2: Biofilm formation in injected dermal filler material

CV Peter Bjerring, Professor, MD, Dr.Sci

469 5 Continent Congress, Barcelona, Spain, 1.-4. September 2016

470 Beauty Skills Lab Course, Molholm Hospital. 24. September 2016

471 European Academy of Dermato-Venereology Annual Congress 28. September-1. October 2016.

472 Galderma Symposium for Danish Dermatologists, Kolding Fjord, Denmark, 28.-29. October 2016.

473 DIAL Dubai, Dubai, Emirates, 9.-13. November 2016

474 Specialist competence course for Danish Dermatologists, Aarhus, Denmark, 16. November 2016

475 International Masters Course on Aging Skin, Paris, France, 25.-29. January 2017.

476 Galderma Advisory Board Meeting, Toronto, Canada, 2.-5. February 2017.

477 Cosmexchange, Trieste, Italy, 16.-18. February 2017.

478 Beauty Skills Lab Course, Molholm Hospital, 11. March 2017

479 Galderma Expert Course in Daylight PDT, Helsinki, Finland, 23. March 2017

480 Danish Cosmetic Plastic Surgery Society, Skovshoved, Denmark, 1. April 2017

481 Anti-Ageing World Congress, Monte Carlo, Monaco, 5.-9. April 2017

481 European Academy of Dermato-Venereology Spring Meeting, Brussels, Belgium 25.-28. April 2017

482 European Society for Laser Dermatology Fostering Course, Geneva, 6.-8. July 2017

483 5 Continent Congress, Barcelona, Spain, 31. August-3. September 2017

484 European Academy of Dermato-Venereology Annual Meeting, Geneva, Switzerland 13.-16.

September 2017

485 Advisory Board Meeting, Skin Ceuticals, Paris, France, 13.-14. October 2017

486 Galderma Symposium for Danish Dermatologists, Kolding Fjord, Denmark, 27.-28. October 2017

487 Specialist competence course for Danish Plastic Surgeons, Aarhus, Denmark, 6. November 2017

488 SkinCeuticals Clinical Meeting, Copenhagen, Denmark, 4. November 2017

489 Euro PDT, Nice, France, 16.-17. March 2018

490 Anti Ageing World Congress, Monte Carlo, Monaco, 4.-7. April 2018

491 European Society for Laser Dermatology Fostering Course, Trieste, 25.-28. April 2018

492 11th 5-Continent Congress, Barcelona, 29-8 til 1/9 2019: Effect of combining topicals with lasers and

IPLs.

493 Aalborg Universitetshospital, Professortiltrædelsesforelæsning. Anvendelsen af lys og lasere i

dermatologi – laser og inkohærent lys til diagnostik og behandling af dermatologiske sygdomme. 24.

September 2019

494 Candela Academy 2019, Rome, 29-8 til 1/9 2019.

1: Photodynamic photorejuvenation with IPL

CV Peter Bjerring, Professor, MD, Dr.Sci

2: The Red Face – the importance of a correct diagnosis and optimized treatment parameters with

IPL and lasers.

3: Optimization of settings for Nd:YAG laser treatment of leg telangiectasies

4: Advanced treatment of scars with IPL and Laser therapy.

495 28th European Academy of Dermato-venereology (EADV) Congress, Madrid, Spain, 29-8 til 1/9 2019:

Critical appraisal of home-use devices for therapeutic indications

496 Aarhus Universitet, Institut for Fysik og Astronomi, LASERLAB.DK’s årsmøde. Dermatologisk

laserbehandling. 22. November 2019.

497 Derm Summit, Stockholm. Advanced Photodynamic Treatment for Aesthetic Indications. 10.-13.

March 2020.

498 29th EADV Virtual Annual Congress. Early Strategies to prevent Scars. 29.-31. October 2020.

499 IMCAS Webinar. Pulsed Dye Lasers versus Intense Pulsed Light, Chairman and introductory lecture.

July 2020.

500

7: Congress Contributions: Poster Presentations

1. Thorling EB, Overvad K, Bjerring P, Ebbesen P. The effect of Selenium on UV-light induced skin

tumours in hairless mice. Symposium on the Role of Cocarcinogens and Pro motors in Human and

Experimental Carcinogenesis, Budapest, May 1983.

2. Zachariae H, Bjerring P. Grunnet E, Thestrup-Pedersen K, Davidsen D. Lymfografi ved tidlig

mycosis fungoides. Nordisk Dematologisk Forenings XXIII Kongres, Oslo, August 1983.

3. Ehlers N, Winther J, Bjerring P, Ebbesen P. Photochemotherapy of Retino-chorioidal Disorders.

Association for Eye Research, 24th Meeting, Wien, August 1983.

4. Thorling EB, Overvad K, Bjerring P. Serum Selenium in Old Age. Third Annual ECP Symposium,

Århus, 19.-21. June 1985.

5. Arendt-Nielsen L, Bjerring P. The Effect of Transcutaneous Nerve Stimulation on Laser induced

pain related cortical responses. VIth World Congress on Pain of the International Association for

the Study of Pain. Hamburg, Pain 1987; Suppl 4: S 366.

6. Bjerring P, Andersen PH. Spectral Reflectance measurements of skin diseases in vivo. 17th World

Congress of dermatology 1987, Berlin.

7. Bjerring, Arendt-Nielsen L. Pre-pain and pain related cortical responses elicited by laser

stimulation. VIth World Congress on Pain of the International Association for the study of pain.

Hamburg, Pain 1987 Suppl.4: S 182.

8. Arendt-Nielsen L, Bjerring P. Pre-pain and pain related evoked potentials elicited by laser pulses.

Electroenceph Clin Neurophysiol 1987; 66: S6.

9. Cramers M, Bjerring P, Halkier-Sørensen L, Zachariae H. Argonlaser behandling: Indikation og

resultat. 25. Nordiske Dermatolog Kongres. København 11.-14. June 1989.

CV Peter Bjerring, Professor, MD, Dr.Sci

10. Andersen PH, Bjerring P. Objektive undersøgelser af den solbeskyttende effekt af sheabutter med

reflektansspektrofotometri, laser Doppler flowmetri of visuel bedømmelse. 25. Nordiske

Dermatolog Kongres. København 11.-14. June 1989.

11. Bjerring P, Nielsen JC, Arendt-Nielsen L. The kinetics of ibuprofen analgesia evaluated by pain

thresholds elicited by short cutaneous argon laser stimulations. VIth World Congress on Pain,

Adelaide, April 1990.

12. Zachariae R, Arendt-Nielsen L, Bjerring P, Gotliebsen K, Nielsen T. The effect of painful argon

laser stimulation on human evoked potentials during hypnotically induced anger and depression.

VIth World Congress on Pain. 1.-6. April 1990, Adelaide.

13. Arendt-Nielsen L, Bjerring P. Non-invasive testing of human mechanical skin impedance. Seventh

Meeting of the European Society of Biomechanics. Aarhus, Denmark, July, 1990.

14. Bjerring P, Arendt-Nielsen L. Effect of long term low and high frequency TNS on pain related

cortical responses. Pain 1987;suppl. 4: 366.

15. Andersen PH, Abrams K, Bjerring P, Maibach H. UVB induced erythema inhibited by topically

applied anti-inflammatory agents. Annual Meeting of the Society of Investigative Dermatology,

Seattle, May 1991.

16. Andersen PH, Nangia A, Bjerring P, Maibach H. Reflectance spectroscopy of skin irritancy in man

using an improved analysis technique. Annual Meeting of the Society of Toxicology. Dallas, Texas,

November 1991.

17. Bjerring P. Objective monitoring of skin vasoconstriction by laser doppler blood flowmetry. XX

World Congress of Dermatology, New York, June 1992.

18. Svensson P, Bak P, Arendt-Nielsen L, Bjerring P. Response of BMS patients to brief nociceptive

heat and mechanical stimuli. American Acacemy of Orofacial pain. Arizona, February 1993.

19. Svensson P, Bak P, Arendt-Nielsen L, Bjerring P. Response of BMS patients to long duration

nociceptive heat, cold pressor and capsaicin stimuli. American Acacemy of Orofacial pain. Arizona,

February 1993.

20. Christensen TM, Bjerring P. The effect of minoxidil on wound epithelialization and

neovascularization. 39th Annual Meeting of the Plastic Surgery Research Council, Ann Arbor,

Michigan, June, 1994.

21. Zachariae H, Bjerring P, Søndergaard K, Halkier-Sørensen L. Occupational scleroderma in males

from a Danish Dermatological Department. IVth Intermational Workshop on Scleroderma

Research. 14.-16. July 1996, Christ's College, Cambridge, UK.

22. Bjerring P, Gault D, Clement M, Lybecker H, Kiernan M, Zachariae H, Egekvist H, Hædersdal M.

Permanent Hair Removal by Ruby Laser - A Preliminary Report. 55th Annual Meeting of the

American Academy of Dermatology, San Francisco, March 1997.

23. H. Egekvist, P. Bjerring, L. Arendt-Nielsen: Relations between pain and mechanical traumatisation

of the human skin by needle insertion. 20th Annual meeting of Scandinavian Association for the

Study of Pain, Aarhus, 17.-20. 1997.

24. Ipsen P, Egekvist H, Aksglæde K, Bjerring P, Jensen SL: Simultaneous video-radiology and

manometry in patients with systemic sclerosis. Clinical value of initial investigation. 29. Nordiske

Gastroenterologimøde, Odense, 12.-14. June 1997.

25. Egekvist H, Madeleine P, Arendt-Nielsen L, Bjerring P, Lervang HH: Habitual insertion velocity of

insulin needles in diabetic patients. 16th International Diabetes Federation (IDF) Congress,

Helsinki, 20.-25. July 1997.

CV Peter Bjerring, Professor, MD, Dr.Sci

26. Egekvist H, Heynderickx I, Arendt-Nielsen L, Bjerring P. Spatial summation of pain related to

mechanical extraction of hair in healthy volunteers. II Congress of the European Federation of

IASP Chapters, Barcelona, 24.-27. September 1997.

27. Haker E, Egekvist H, Bjerring P. Effect of sensory stimulation (acupuncture) on sympathetic and

parasympathetic activity in healthy subjects. II Congress of the European Federation of IASP

Chapters, Barcelona, 24.-27 September 1997.

28. Zachariae H, Egekvist H, Ipsen P, Bjerring P, Aksglæde K, Thommesen P: Clinical value of first

investigation of esophagus function in patients with systemic sclerosis. Systemic Sclerosis towards

the year 2000. International Congress on Scleroderma. Milano, 3.-5. October 1997.

29. Egekvist H, Bjerring P, Arendt-Nielsen L: Mechanical traumatization by needle insertion into the

human skin and pain perception. II International Congress on Sensory Stimulation in Pain and

Diseases. Karolinska Institute, Stockholm, 17.-18. October 1997.

CV Peter Bjerring, Professor, MD, Dr.Sci

8: Editorial boards

Skin Research and Technology,

Journal of Cosmetic and Laser Therapy

9: Journal referee

Archives of Dermatological Research,

Acta Dermato-Venereologica,

Skin Research and Technology,

Vascular Research,

Ugeskrift for Læger,

Journal of Cosmetic and Laser Therapy,

Acta Oncologica

10: Fellowships: scientific societies and -associations

The Danish Medical Association (DMA),

The Danish Dermatological Society (DDS),

The Organization for Danish Practicing Dermatologists (DDO)

European Laser Association (ELA),

The American Society for Laser Medicine and Surgery (ASLMS)

The American Academy of Dermatology (AAD)

European Society for Lasers and Energy-based Devices (ESLD) - Former President

European Society for Lasers in Aesthetic Surgery (ESLAS) - Former Vice President

11: Boards and Committees

1985-1990 : Vice President, Danish Society for Laser Therapy.

1991-2005 : Treasurer, Scandinavian Society for Laser Therapy.

1994- : The Laser Committee, Danish Dermatologists’ Organization

2000-2003 : Board Member, European Society for Laser Dermatology

2003-2004 : President, European Society for Lasers and Energy-based Devices

2005-2009 : Board Member, European Society for Laser Dermatology

2004-2010 : Vice President, European Society for Lasers in Aesthetic Surgery

2019- : Board Member, The Cosmetic Dermatology Committee of DDS

12: Scientific supervision

CV Peter Bjerring, Professor, MD, Dr.Sci

Supervisor for Ph.D. students:

Peter Svensson - Quantificaton of argon laser-induced nociception from

human oral mucosa and facial skin.

Henrik Løvschall - Effects of low level laser (LLL) irradiation in cultures of

human oral mucosa.

Peter Hundevadt Andersen: Reflectance spectroscopy of human skin

Bobby Zachariae - Psycho-immunology

Seung Eun - Skin microbiology

Michael Martini Jørgensen - Psycho immunology

Helle Øster – Psycho immunology

Anders Fønns – Experimental skin inflammation

Smruti Shevale – Experimental skin pain

Caewyn Ash

Godfrey Town

Nick van der Beek

13: External Examinator at Ph.D Theses and Doctoral Dissertations:

Eli Janne Fiskerstrand, Norway – Pulsed dye laser treatment of haemangiomas (Dr.Sci(Med)

Merete Hædersdal, Denmark - Dermatological laser treatment (both Ph.D. and Dr.Sci (Med)

Anne Quirinia, Denmark – Skin wound healing and ischaemia

Carinne Schroeter, Maarstricht, The Netherlands – IPL and laser treatment and histology

Jaap de Leeuw, Erasmus University, Rotterdam the Netherlands – Pulsed dye

laser treatments and liposomes in dermatology. 2009.

Andrew Thomas, Swansea University, Wales – The construction of an

improved pulsed dye laser. 2006.

Anna Victoria Giblin, Swansea University, Wales – Optical detection of

malignant melanoma. 2008.

Michael Kiernan, Swansea University, Wales – The pulsed dye laser

Frederik Olivarius, Denmark – Urocanic acid and skin cancer

Gareth Stockman, Swansea University, Wales, - Laser light and

chondrocyte Activity, 2008.

Robert Trow, Swansea University, Wales - Ruby laser for hair removal.

2001.

CV Peter Bjerring, Professor, MD, Dr.Sci

Yen Song Liew, Swansea University, Wales – photodynamic therapy. 2005.

Judith Ostertag, Maastricht, The Netherlands – Laser resurfacing of

potentially malignant skin diseases.

Caerwyn Ash, Swansea University - Optimising Output Dosimetry of a

Broadband Pulsed Light Source for the Removal of Unwanted Hair. 2009

Daniele Doneddu, Swansea University, Wales – Nd:YAG laser with

improved temporal pulse structure, 2010.

Lleucu Davies, Swansea University, Wales - The Effect of Optical

Irradiation on Stem Cell Properties and Behaviour, 2014.

Ina Laura Pieper, Swansea University, Wales - Product development of a

mesenchymal stem cell therapy for the treatment of myocardial infarction,

2014.

Ryan Woodward, Swansea, Wales - The Effect of Low-Fluence Intense

Pulsed Light on Human Dermal Fibroblasts for Application in Non-Invasive

Type II Photorejuvenation, 2015.

Elisabeth Hjardem Taudorf, Copenhagen University - Laser-assisted

Delivery of Topical Methotrexate - In vitro investigations. 2015.

Farhana Tegwen Malik - A study of dew harvesting cacti to inform the

development of a biomimetic inspired water collection device 2016

Katrine Elisabeth Karmisholt - Laser Treatment in Early Wound Healing and the

Clinical Effect on Scar Formation 2018

Steve Yap - Assessing Evidence-Based Medicine: An Investigation into

Complementary and Traditional Medical Practices prior to Enforcement of the

Traditional and Complementary Medicine Act 2016 (Act 775) in Malaysia. 2018.

Ann-Sofie Sonne Holm-Schou - Skin cancer – Incidence validation and risk

estimation related to skin phototype and UVR dose. 2018

Giedre Biliauskiene – Skin phototype assessment:

certainties and uncertainties. 2019

Katrine Togsverd-Bo - Keratinocyte dysplasia in organ transplant recipients:

Treatment and prevention with photodynamic therapy and non-invasively measured

skin photodamage. 2020 Dr.Sci.(Med.).

CV Peter Bjerring, Professor, MD, Dr.Sci

14: Honours

2008

The Danish Royal Order of Chivalry:

The Order of Dannebrog (Knighthood), appointed by Her Majesty Queen Margrethe II

of Denmark in recognition of research as well as initiation and democratization of clinical

dermatological laser treatments in Denmark.

2007

The Laser Award Trier, Germany

2003

The William Nielsen Prize, Denmark

1986

Gold Medal Prize -Aarhus University, Denmark